100050 : AARSKOG SYNDROME 100070 : ABDOMINAL AORTIC ANEURYSM 100100 : ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM 100200 : ABDUCENS PALSY *100300 : ABSENCE DEFECT OF LIMBS, SCALP, AND SKULL *100500 : ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER *100600 : ACANTHOSIS NIGRICANS *100640 : ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1; ALDH1A1 *100650 : ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2 *100660 : ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1 *100670 : ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1; ALDH1B1 100675 : ACETAMINOPHEN METABOLISM *100678 : ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2 100680 : ACETYLCHOLINESTERASE EXPRESSION; ACEE *100690 : CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1 100700 : ACHARD SYNDROME *100710 : CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1 *100720 : CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND *100725 : CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE *100730 : CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG ^100735 : MOVED TO 142445 *100740 : ACETYLCHOLINESTERASE; ACHE *100790 : ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG-LIKE 1; ASCL1 #100800 : ACHONDROPLASIA; ACH *100820 : ACHOO SYNDROME *100850 : ACONITASE, MITOCHONDRIAL; ACO2 *100880 : ACONITASE, SOLUBLE; ACO1 *100900 : ACONITATE HYDRATASE, SOLUBLE *101000 : NEUROFIBROMATOSIS, TYPE II; NF2 101120 : ACROCEPHALOPOLYSYNDACTYLY TYPE III #101200 : APERT SYNDROME #101400 : SAETHRE-CHOTZEN SYNDROME; SCS #101600 : PFEIFFER SYNDROME *101800 : ACRODYSOSTOSIS 101805 : ACROFACIAL DYSOSTOSIS, CATANIA TYPE 101840 : ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT *101850 : ACROKERATOELASTOIDOSIS; AKE *101900 : ACROKERATOSIS VERRUCIFORMIS 102000 : ACROLEUKOPATHY, SYMMETRIC *102100 : ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA *102150 : ACROMEGALOID FACIAL APPEARANCE SYNDROME *102200 : ACROMEGALY *102300 : ACROMELALGIA, HEREDITARY *102350 : ACROMIAL DIMPLES 102370 : ACROMICRIC DYSPLASIA 102400 : ACROOSTEOLYSIS *102480 : ACROSIN; ACR 102490 : ACRORENOOCULAR SYNDROME *102500 : ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE *102510 : ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF 102520 : ACRORENAL SYNDROME *102525 : ACROSOMAL VESICLE PROTEIN 1; ACRV1 102530 : ACROSOME MALFORMATION OF SPERMATOZOA *102540 : ACTIN, ALPHA, CARDIAC MUSCLE; ACTC *102545 : ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2 ^102550 : MOVED TO 102630 *102560 : ACTIN, GAMMA-1; ACTG1 *102565 : FILAMIN C; FLNC *102570 : ACTIN, PLATELET *102573 : ACTININ, ALPHA-2; ACTN2 *102574 : ACTININ, ALPHA-3; ACTN3 *102575 : ACTININ, ALPHA-1; ACTN1 *102576 : ACTIVIN A RECEPTOR, TYPE I; ACVR1 *102577 : ACTIVATOR 1, 37-KD SUBUNIT; RFC4 *102578 : ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML *102579 : REPLICATION FACTOR C, 140-KD SUBUNIT; RFC1 *102581 : ACTIVIN A RECEPTOR, TYPE II; ACVR2 *102582 : SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3 102590 : ACYLASE, COBALT-ACTIVATED *102593 : ACYLOXYACYL HYDROLASE; AOAH *102595 : ACYLPHOSPHATASE 2, MUSCLE TYPE; ACYP2 *102600 : ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT *102610 : ACTIN, ALPHA, SKELETAL MUSCLE 1; ACTA1 *102620 : ACTIN, ALPHA, SMOOTH MUSCLE, AORTIC; ACTSA *102630 : ACTIN, BETA; ACTB ^102640 : MOVED TO 102630 *102642 : STEROL O-ACYLTRANSFERASE; SOAT *102645 : ACYLPEPTIDE HYDROLASE; APH 102650 : ADACTYLIA, UNILATERAL 102660 : ADAMANTINOMA OF LONG BONES *102670 : MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1 *102680 : ADDUCIN 1; ADD1 *102681 : ADDUCIN 2; ADD2 102699 : ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1 *102700 : ADENOSINE DEAMINASE; ADA 102710 : ADENOSINE DEAMINASE COMPLEXING PROTEIN 1; ADCP1 *102720 : DIPEPTIDYL PEPTIDASE IV; DPP4 102730 : ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO *102750 : ADENOSINE KINASE; ADK *102770 : ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1 *102771 : ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2 *102772 : ADENOSINE MONOPHOSPHATE DEAMINASE 3; AMPD3 *102775 : ADENOSINE A1 RECEPTOR; ADORA1 *102776 : ADENOSINE A2 RECEPTOR; ADORA2A *102777 : ADENOSINE A2 RECEPTOR-LIKE; ADORA2L1 *102800 : ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO #102900 : ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES *102910 : ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, BETA SUBUNIT; ATP5B ^102920 : REMOVED FROM DATABASE ^102930 : REMOVED FROM DATABASE ^102940 : REMOVED FROM DATABASE ^102970 : REMOVED FROM DATABASE *102980 : ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1; ADCYAP1 *102981 : ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, RECEPTOR FOR; ADCYAP1R1 102990 : ADENYLATE KINASE, MUSCLE, DEFICIENCY OF *103000 : ADENYLATE KINASE 1; AK1 *103020 : ADENYLATE KINASE 2; AK2 *103030 : ADENYLATE KINASE 3; AK3 *103050 : ADENYLOSUCCINATE LYASE; ADSL *103060 : ADENYLOSUCCINATE SYNTHETASE; ADSS *103070 : ADENYLATE CYCLASE 8; ADCY8 *103071 : ADENYLATE CYCLASE 2; ADCY2 *103072 : ADENYLATE CYCLASE 1; ADCY1 103100 : ADIE SYNDROME *103180 : ADP-RIBOSYLATION FACTOR 1; ARF1 *103188 : ADP-RIBOSYLATION FACTOR 5; ARF5 *103190 : ADP-RIBOSYLATION FACTOR 3; ARF3 *103195 : ADIPOSE DIFFERENTIATION-RELATED PROTEIN; ADRP 103200 : ADIPOSIS DOLOROSA *103220 : SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 4; SLC25A4 103230 : ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL *103260 : ADRENODOXIN; ADX *103270 : ADRENODOXIN REDUCTASE; ADXR *103275 : ADRENOMEDULLIN; ADM *103280 : H19 GENE; H19 #103285 : ADULT SYNDROME 103300 : AGLOSSIA-ADACTYLIA *103320 : AGRIN; AGRN ^103321 : MOVED TO 128239 *103390 : AHNAK NUCLEOPROTEIN 103400 : AINHUM *103420 : ALACRIMA, CONGENITAL #103470 : ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS #103500 : TIETZ SYNDROME #103580 : ALBRIGHT HEREDITARY OSTEODYSTROPHY; AHO 103581 : ALBRIGHT HEREDITARY OSTEODYSTROPHY 2; AHO2 *103600 : ALBUMIN; ALB *103700 : ALCOHOL DEHYDROGENASE 1A, ALPHA POLYPEPTIDE; ADH1 *103710 : ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE; ADH5 *103720 : ALCOHOL DEHYDROGENASE 1B, BETA POLYPEPTIDE; ADH2 *103730 : ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE; ADH3 *103735 : ALCOHOL DEHYDROGENASE 6; ADH6 *103740 : ALCOHOL DEHYDROGENASE 4; ADH4 #103780 : ALCOHOLISM *103800 : ALDER ANOMALY *103830 : ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1; AKR1A1 *103850 : ALDOLASE A, FRUCTOSE-BISPHOSPHATE; ALDOA *103870 : ALDOLASE C, FRUCTOSE-BISPHOSPHATE; ALDOC *103880 : ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1; AKR1B1 *103890 : ALDOSE REDUCTASE M; ARM #103900 : HYPERALDOSTERONISM, FAMILIAL, TYPE I 103920 : ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS *103950 : ALPHA-2-MACROGLOBULIN; A2M 104000 : ALOPECIA AREATA 104100 : ALOPECIA CONGENITA WITH KERATOSIS PALMOPLANTARIS 104110 : ALOPECIA, FAMILIAL FOCAL *104130 : ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY *104145 : AFAMIN; AFM *104150 : ALPHA-FETOPROTEIN; AFP *104155 : ALPHA-FETOPROTEIN ENHANCER-BINDING PROTEIN *104160 : ALPHA-GLUCOSIDASE, NEUTRAL, AB FORM; GANAB *104170 : ALPHA-GALACTOSIDASE B; GALB *104175 : GLYCOPROTEIN ALPHA-GALACTOSYLTRANSFERASE 1; GGTA1 *104180 : ALPHA-GLUCOSIDASE C, NEUTRAL; GANC *104200 : ALPORT SYNDROME, AUTOSOMAL DOMINANT *104210 : ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A *104219 : ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D *104220 : ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B *104221 : ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A ^104222 : MOVED TO 104219 *104225 : LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1; LRPAP1 *104230 : FUCOSYLTRANSFERASE 4; FUT4 *104240 : SIALYLTRANSFERASE 4C; SIAT4C *104250 : ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C *104260 : ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B 104290 : ALTERNATING HEMIPLEGIA OF CHILDHOOD #104300 : ALZHEIMER DISEASE; AD #104310 : ALZHEIMER DISEASE 2; AD2 *104311 : ALZHEIMER DISEASE, FAMILIAL, TYPE 3 104350 : AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM 104400 : AMELIA AND TERMINAL TRANSVERSE HEMIMELIA #104500 : AMELOGENESIS IMPERFECTA 2, HYPOPLASTIC LOCAL, AUTOSOMAL DOMINANT; AIH2 *104510 : AMELOGENESIS IMPERFECTA, HYPOMATURATION-HYPOPLASIC TYPE, WITH TAURODONTISM; AIHHT *104530 : AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE *104570 : AMELOONYCHOHYPOHIDROTIC SYNDROME 104600 : AMENORRHEA-GALACTORRHEA SYNDROME *104610 : AMILORIDE-BINDING PROTEIN 1; ABP1 *104613 : CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A; CCT6A *104614 : SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1; SLC3A1 *104615 : SOLUTE CARRIER FAMILY 7, MEMBER 1; SLC7A1 *104620 : AMINOACYLASE 1; ACY1 *104640 : AMPHIREGULIN; AREG *104650 : AMYLASE, PANCREATIC, A; AMY2A *104660 : AMYLASE, PANCREATIC, B; AMY2B *104700 : AMYLASE, SALIVARY; AMY1 *104701 : AMYLASE, SALIVARY, B; AMY1B *104702 : AMYLASE, SALIVARY, C; AMY1C *104740 : AMYLOID BETA A4 PRECURSOR PROTEIN-LIKE 1; APPL1 *104750 : SERUM AMYLOID A1; SAA1 *104751 : SERUM AMYLOID A2; SAA2 *104752 : SERUM AMYLOID A4; SAA4 *104760 : AMYLOID BETA A4 PRECURSOR PROTEIN; APP *104770 : AMYLOID P COMPONENT, SERUM; APCS *104775 : AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1; APLP1 *104776 : AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2; APLP2 #105120 : AMYLOIDOSIS V #105150 : AMYLOIDOSIS VI #105200 : AMYLOIDOSIS, FAMILIAL VISCERAL *105210 : AMYLOIDOSIS VII *105250 : AMYLOIDOSIS, PRIMARY CUTANEOUS 105300 : AMYOTROPHIC DYSTONIC PARAPLEGIA #105400 : AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1 105500 : AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX OF GUAM *105550 : AMYOTROPHIC LATERAL SCLEROSIS WITH FRONTOTEMPORAL DEMENTIA 105563 : ANAL SPHINCTER DYSPLASIA; ASDP 105565 : ANAL SPHINCTER MYOPATHY, INTERNAL 105570 : ANDROSTENONE, ABILITY TO SMELL 105580 : ANAL CANAL CARCINOMA *105590 : ANAPLASTIC LYMPHOMA KINASE; ALK *105600 : ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III; CDAN3 #105650 : DIAMOND-BLACKFAN ANEMIA, AUTOSOMAL DOMINANT *105800 : ANEURYSM, INTRACRANIAL BERRY 105805 : ANEURYSM OF INTERVENTRICULAR SEPTUM #105830 : ANGELMAN SYNDROME; AS 105835 : ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED *105850 : ANGIOGENIN; ANG 106050 : ANGIOMA SERPIGINOSUM *106070 : ANGIOMA, HEREDITARY NEUROCUTANEOUS #106100 : ANGIOEDEMA, HEREDITARY; HAE *106150 : ANGIOTENSIN I; AGT 106160 : ANGIOTENSIN II BINDING PROTEIN *106165 : ANGIOTENSIN RECEPTOR 1; AGTR1 *106180 : ANGIOTENSIN I-CONVERTING ENZYME; ACE 106190 : ANHIDROSIS, FAMILIAL GENERALIZED, WITH NORMAL SWEAT GLANDS *106195 : SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3; SLC4A3 #106200 : ANIRIDIA; AN1 *106210 : PAIRED BOX GENE 6; PAX6 106220 : ANIRIDIA AND ABSENT PATELLA 106230 : ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT 106240 : ANISOCORIA 106250 : ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE #106260 : ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE 106280 : ANKYLOGLOSSIA *106300 : ANKYLOSING SPONDYLITIS; AS 106400 : ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS *106410 : ANKYRIN 2; ANK2 *106490 : ANNEXIN A3; ANXA3 *106491 : ANNEXIN A4; ANXA4 106500 : ANNULAR ERYTHEMA #106600 : HYPODONTIA, AUTOSOMAL DOMINANT; HYD1 *106700 : TOTAL ANOMALOUS PULMONARY VENOUS RETURN; TAPVR1 106750 : ANONYCHIA WITH FLEXURAL PIGMENTATION 106900 : ANONYCHIA-ECTRODACTYLY 106990 : ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY *106995 : ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES 107000 : ANONYCHIA-ONYCHODYSTROPHY *107100 : ANORECTAL ANOMALIES 107200 : ANOSMIA, CONGENITAL *107240 : ANTIGEN MSK39 IDENTIFIED BY MONOCLONAL ANTIBODY 5.1H11; MSK39 #107250 : ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD *107253 : ANTIGEN MDF1 IDENTIFIED BY MONOCLONAL ANTIBODY A-3A4; MDF1 *107254 : ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8; MIC12 *107257 : ANTIGEN MSK3 IDENTIFIED BY MONOCLONAL ANTIBODY M68; MSK3 *107260 : ANTIGEN MSK41 IDENTIFIED BY MONOCLONAL ANTIBODY E3; MSK41 *107265 : CD19 ANTIGEN; CD19 *107266 : CD22 ANTIGEN; CD22 *107269 : CD44 ANTIGEN; CD44 *107270 : CD38 ANTIGEN; CD38 *107271 : CD59 ANTIGEN P18-20; CD59 *107272 : CD72 ANTIGEN; CD72 *107273 : CD69 ANTIGEN; CD69 *107280 : ALPHA-1-ANTICHYMOTRYPSIN; AACT *107285 : SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SLPI *107290 : ANTIPYRINE METABOLISM *107300 : ANTITHROMBIN III DEFICIENCY *107310 : SOLUTE CARRIER FAMILY 9, ISOFORM A1; SLC9A1 107320 : ANTIPHOSPHOLIPID SYNDROME *107323 : ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1; ALDH7A1 *107325 : ANTISENSE ERCC1; ASE1 *107400 : PROTEASE INHIBITOR 1; PI *107410 : PROTEASE INHIBITOR 1-LIKE; PIL 107440 : ANTIVIRAL STATE REPRESSOR, REGULATOR OF; AVRR *107450 : INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1 ^107460 : MOVED TO 107450 *107470 : INTERFERON, GAMMA, RECEPTOR 1; IFNGR1 #107480 : TOWNES-BROCKS SYNDROME; TBS 107500 : AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION 107550 : AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA *107580 : TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A *107600 : APLASIA CUTIS CONGENITA 107601 : APLASIA CUTIS CONGENITA AND COARCTATION OF AORTA; ACCCA 107640 : APNEA, CENTRAL SLEEP *107650 : APNEA, OBSTRUCTIVE SLEEP *107670 : APOLIPOPROTEIN A-II; APOA2 *107680 : APOLIPOPROTEIN A-I; APOA1 *107690 : APOLIPOPROTEIN A-IV; APOA4 107700 : APPENDICITIS, PRONENESS TO *107710 : APOLIPOPROTEIN C-I; APOC1 *107720 : APOLIPOPROTEIN C-III; APOC3 *107730 : APOLIPOPROTEIN B; APOB *107740 : APOLIPOPROTEIN D; APOD *107741 : APOLIPOPROTEIN E; APOE *107748 : APEX NUCLEASE; APEX #107750 : ARBITRARY RESTRICTION POLYMORPHISM 1 107760 : APOLIPOPROTEIN F; APOF *107770 : LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1 *107773 : NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2 *107776 : AQUAPORIN 1; AQP1 *107777 : AQUAPORIN 2; AQP2 107800 : ARCUS CORNEAE *107820 : ARGINYL-tRNA SYNTHETASE; RARS *107830 : ARGINASE II; ARG2 ^107840 : MOVED TO 215700 107850 : ARM FOLDING PREFERENCE 107900 : ARMS, MALFORMATION OF *107910 : CYTOCHROME P450, SUBFAMILY XIX; CYP19 107920 : AROMATIC ALPHA-KETO ACID REDUCTASE *107930 : AROMATIC L-AMINO ACID DECARBOXYLASE; AADC *107940 : ARRESTIN, BETA, 1; ARRB1 *107941 : ARRESTIN, BETA, 2; ARRB2 *107950 : ARRHENOBLASTOMA--THYROID ADENOMA *107970 : ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1 108000 : ARTERIES, ANOMALIES OF #108010 : ARTERIOVENOUS MALFORMATIONS OF THE BRAIN 108050 : ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS 108100 : ARTHRITIS, SACROILIAC 108110 : ARTHROGRYPOSIS MULTIPLEX CONGENITA; AMC *108120 : ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE 1; AMCD1 108130 : ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE II 108140 : ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE II, WITH CRANIOFACIAL ABNORMALITIES 108145 : ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES 108200 : ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS #108300 : STICKLER SYNDROME, TYPE I; STL1 108320 : ARTICHOKE, MODIFICATION OF TASTE BY *108330 : CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1A1 #108340 : ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY *108345 : N-ACETYLTRANSFERASE 1; NAT1 *108355 : GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; GRB2 *108360 : ASIALOGLYCOPROTEIN RECEPTOR 1; ASGR1 *108361 : ASIALOGLYCOPROTEIN RECEPTOR 2; ASGR2 *108370 : ASPARAGINE SYNTHETASE; ASNS 108390 : ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY ^108400 : REMOVED FROM DATABASE *108410 : ASPARAGINYL-tRNA SYNTHETASE; NARS 108420 : ASPERMIOGENESIS FACTOR; ASG 108450 : ASYMMETRIC SHORT STATURE SYNDROME #108500 : EPISODIC ATAXIA, TYPE 2; EA2 *108600 : ATAXIA, SPASTIC, AUTOSOMAL DOMINANT; SAX1 *108650 : ATAXIA, SPASTIC, WITH CONGENITAL MIOSIS 108700 : ATAXIA WITH FASCICULATIONS 108720 : ATELOSTEOGENESIS, TYPE I *108721 : ATELOSTEOGENESIS, TYPE III 108725 : ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS *108728 : ATP CITRATE LYASE; ACLY *108729 : ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, GAMMA SUBUNIT 1; ATP5C1 *108730 : ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1; ATP2A1 *108731 : ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1 *108732 : ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4 *108733 : ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2 *108740 : ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2 *108745 : ATPase, H+ TRANSPORTING, LYSOSOMAL; ATP6L *108746 : ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E; ATP6V1E *108760 : ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS 108770 : ATRIAL CARDIOMYOPATHY WITH HEART BLOCK *108780 : NATRIURETIC PEPTIDE PRECURSOR A; NPPA *108800 : ATRIAL SEPTAL DEFECT; ASD #108900 : ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS 108950 : ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL *108960 : NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1 *108961 : NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2 *108962 : NATRIURETIC PEPTIDE RECEPTOR C; NPR3 108970 : ATRIOPEPTIDASE 108980 : ATRIOVENTRICULAR CONDUCTION TIME *108985 : ATROPHIA AREATA; AA *108990 : ATTACHED CELL ANTIGEN 28.3.7; MIC7 *109000 : AURICULOOSTEODYSPLASIA 109050 : AUROCEPHALOSYNDACTYLY *109090 : SJOGREN SYNDROME ANTIGEN B; SSB *109091 : CALRETICULIN; CALR *109092 : SJOGREN SYNDROME ANTIGEN A1; SSA1 #109100 : AUTOIMMUNE DISEASES *109110 : AUTONOMOUSLY REPLICATING SEQUENCE 1 109120 : AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES 109130 : AXIAL OSTEOMALACIA *109135 : AXL RECEPTOR TYROSINE KINASE; AXL #109150 : MACHADO-JOSEPH DISEASE; MJD *109160 : AZOTEMIA, FAMILIAL *109170 : LYMPHOCYTE ANTIGEN 117; LY117 109180 : BABOON M7 VIRUS INTEGRATION SITE; BEVI *109190 : SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5; SLC1A5 *109195 : BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI *109200 : ALOPECIA, ANDROGENETIC *109270 : SOLUTE CARRIER FAMILY 4, ANION EXCHANGER, MEMBER 1; SLC4A1 *109280 : SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2; SLC4A2 109300 : BANKI SYNDROME *109350 : GASTROESOPHAGEAL REFLUX 109390 : BASAL CELL CARCINOMAS WITH MILIA AND COARSE, SPARSE HAIR #109400 : BASAL CELL NEVUS SYNDROME; BCNS *109480 : BASIGIN; BSG 109500 : BASILAR IMPRESSION, PRIMARY *109530 : CD48 ANTIGEN; CD48 *109535 : TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 5; TNFRSF5 109540 : B-CELL GROWTH FACTOR; BCGF *109543 : B-CELL MALIGNANCY, LOW-GRADE *109545 : TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17; TNFRSF17 *109560 : B-CELL LEUKEMIA/LYMPHOMA 3; BCL3 *109565 : B-CELL LYMPHOMA 6; BCL6 *109580 : B-CELL TRANSLOCATION GENE 1; BTG1 109600 : BEETURIA *109610 : BENZODIAZEPINE RECEPTOR, PERIPHERAL TYPE; BZRP *109630 : BETA-1-ADRENERGIC RECEPTOR; ADRB1 *109635 : BETA-ADRENERGIC RECEPTOR KINASE 1; ADRBK1 *109636 : BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2 *109640 : BETA-GLYCEROL PHOSPHATASE; GPB 109650 : BEHCET SYNDROME *109660 : BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT 109670 : BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS *109675 : SIALYLTRANSFERASE 1; SIAT1 *109684 : 17-@BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1 *109685 : 17-@BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2 *109690 : BETA-2-ADRENERGIC RECEPTOR; ADRB2 *109691 : BETA-3-ADRENERGIC RECEPTOR; ADRB3 *109700 : BETA-2-MICROGLOBULIN; B2M *109710 : BETA-2-MICROGLOBULIN REGULATOR; B2MR *109715 : 3-@BETA-HYDROXYSTEROID DEHYDROGENASE/DELTA-ISOMERASE, TYPE I 109720 : BILIARY CIRRHOSIS, PRIMARY; PBC 109730 : BICUSPID AORTIC VALVE 109740 : BIFID NOSE *109750 : BILIVERDIN REDUCTASE A; BLVRA *109760 : 5-@HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A *109770 : CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1 *109780 : BKM DNA #109800 : BLADDER CANCER 109820 : BLADDER DIVERTICULUM 109900 : BLEPHAROCHALASIS AND DOUBLE LIP 110000 : BLEPHAROCHALASIS, SUPERIOR 110050 : BLEPHARONASOFACIAL MALFORMATION SYNDROME #110100 : BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES 110150 : BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS 110250 : BLOOD GROUP--ABO SUPPRESSOR *110300 : ABO BLOOD GROUP; ABO 110310 : BLOOD GROUP--ABH ANTIGEN, TYPE 2 *110350 : BLOOD GROUP--AHONEN; AN #110450 : BLOOD GROUP--COLTON; CO #110500 : BLOOD GROUP--DIEGO SYSTEM; DI #110600 : BLOOD GROUP--DOMBROCK SYSTEM; DO *110700 : BLOOD GROUP--DUFFY SYSTEM; FY 110720 : BLOOD GROUP--En *110750 : BLOOD GROUP--GERBICH; Ge #110800 : BLOOD GROUP--I SYSTEM; Ii *110900 : BLOOD GROUP--KELL-CELLANO SYSTEM; KEL *111000 : BLOOD GROUP--KIDD SYSTEM; JK *111100 : FUCOSYLTRANSFERASE 3; FUT3 *111130 : BLOOD GROUP--LKE; LKE *111150 : BLOOD GROUP--LUTHERAN INHIBITOR *111200 : BLOOD GROUP--LUTHERAN SYSTEM; LU *111250 : LANDSTEINER-WIENER BLOOD GROUP; LW *111300 : BLOOD GROUP--MN LOCUS; MN 111360 : BLOOD GROUP--NEWFOUNDLAND; NFLD #111380 : BLOOD GROUP--OK; OK *111400 : BLOOD GROUP--P SYSTEM *111410 : BLOOD GROUP--P SYSTEM, SECOND LOCUS #111500 : BLOOD GROUP--PRIVATE SYSTEMS #111600 : BLOOD GROUP--PUBLIC SYSTEMS 111620 : BLOOD GROUP--RADIN ANTIGEN; Rd *111680 : RHESUS BLOOD GROUP, D ANTIGEN; RHD #111690 : BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE *111700 : RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE *111730 : N-ACETYLGALACTOSAMINYLTRANSFERASE II *111740 : BLOOD GROUP--Ss LOCUS; Ss *111750 : BLOOD GROUP--SCIANNA SYSTEM; Sc *111800 : BLOOD GROUP--STOLTZFUS SYSTEM; Sf *112000 : BLOOD GROUP--Ul SYSTEM; UL #112010 : BLOOD GROUP--WALDNER TYPE; WD #112050 : BLOOD GROUP--WRIGHT ANTIGEN; Wr #112100 : BLOOD GROUP--Yt SYSTEM; YT *112200 : BLUE RUBBER BLEB NEVUS *112203 : CD80 ANTIGEN; CD80 *112205 : CD79A ANTIGEN; CD79A *112210 : MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1; MS4A1 112240 : BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES *112250 : DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA *112260 : GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE; BGLAP *112261 : BONE MORPHOGENETIC PROTEIN 2; BMP2 *112262 : BONE MORPHOGENETIC PROTEIN 4; BMP4 *112263 : BONE MORPHOGENETIC PROTEIN 3; BMP3 *112264 : BONE MORPHOGENETIC PROTEIN 1; BMP1 *112265 : BONE MORPHOGENETIC PROTEIN 5; BMP5 *112266 : BONE MORPHOGENETIC PROTEIN 6; BMP6 *112267 : BONE MORPHOGENETIC PROTEIN 7; BMP7 112270 : BONE PAIN, PERIODIC *112300 : BOOK SYNDROME 112310 : BOOMERANG DYSPLASIA 112350 : BOWING OF LEGS, ANTERIOR, WITH DWARFISM 112370 : BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY *112410 : HYPERTENSION WITH BRACHYDACTYLY 112430 : BRACHYDACTYLY, LONG-THUMB TYPE 112440 : BRACHYDACTYLY, COMBINED B AND E TYPES 112450 : BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION #112500 : BRACHYDACTYLY, TYPE A1; BDA1 *112600 : BRACHYDACTYLY, TYPE A2; BDA2 *112700 : BRACHYDACTYLY, TYPE A3; BDA3 *112800 : BRACHYDACTYLY, TYPE A4; BDA4 *112900 : BRACHYDACTYLY, TYPE A5, WITH NAIL DYSPLASIA 112910 : BRACHYDACTYLY, TYPE A6; BDA6 #113000 : BRACHYDACTYLY, TYPE B1; BDB1 *113100 : BRACHYDACTYLY, TYPE C; BDC *113200 : BRACHYDACTYLY, TYPE D; BDD *113300 : BRACHYDACTYLY, TYPE E; BDE 113301 : BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II 113310 : BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA 113400 : BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA 113450 : BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME 113470 : BRACHYMESOMELIA-RENAL SYNDROME 113475 : BRACHYMETATARSUS IV 113477 : BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME 113480 : BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME 113500 : BRACHYRACHIA *113503 : BRADYKININ RECEPTOR B2; BDKRB2 *113505 : BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF *113508 : TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM; YWHAH *113510 : BRAIN-SPECIFIC PROTEIN Pc-1 *113520 : BRANCHED-CHAIN AMINOTRANSFERASE 1; BCAT1 *113530 : BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2 113600 : BRANCHIAL CLEFT ANOMALIES 113610 : BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA *113620 : BRANCHIAL CLEFTS WITH CHARACTERISTIC FACIES, GROWTH RETARDATION, IMPERFORATE NASOLACRIMAL DUCT, AND PREMATURE AGING *113630 : BREAKPOINT CLUSTER REGION-LIKE 2; BCRL2 *113640 : BREAKPOINT CLUSTER REGION-LIKE 3; BCRL3 #113650 : BRANCHIOOTORENAL DYSPLASIA *113660 : BREAKPOINT CLUSTER REGION-LIKE 4; BCRL4 113670 : BREAST, UNILATERAL GIANT 113700 : BREASTS AND NIPPLES, ABSENCE OF *113703 : RIBOSOMAL PROTEIN L13; RPL13 *113705 : BREAST CANCER, TYPE 1; BRCA1 *113710 : TREFOIL FACTOR 1; TFF1 *113720 : BREAST CANCER-ASSOCIATED DF3 ANTIGEN *113721 : BREAST CANCER-RELATED REGULATOR OF TP53 *113725 : POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2; POU4F2 *113730 : UNCOUPLING PROTEIN 1; UCP1 *113750 : HAIR COLOR 1; HCL1 #113800 : BULLOUS ERYTHRODERMA ICHTHYOSIFORMIS CONGENITA OF BROCQ *113810 : BULLOUS PEMPHIGOID ANTIGEN 1; BPAG1 *113811 : COLLAGEN, TYPE XVII, ALPHA-1; COL17A1 #113900 : PROGRESSIVE FAMILIAL HEART BLOCK, TYPE I; PFHBI *113950 : BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT *113955 : BUNGAROTOXIN, ALPHA, RECEPTOR FOR; BGTXR 113960 : BUTYRYLESTERASE 1 #113970 : BURKITT LYMPHOMA; BL *113995 : COMPLEMENT COMPONENT 5 RECEPTOR 1; C5R1 *114000 : CAFFEY DISEASE *114010 : CARBAMOYLPHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE; CAD *114019 : CADHERIN 15; CDH15 *114020 : CADHERIN 2; CDH2 *114021 : CADHERIN 3; CDH3 *114025 : CATENIN, ALPHA-2; CTNNA2 #114030 : CAFE-AU-LAIT SPOTS, MULTIPLE *114050 : CALBINDIN 1; CALB1 *114051 : CALBINDIN 2; CALB2 114065 : CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL *114070 : ANNEXIN A6; ANXA6 *114078 : CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA; CAMK2A *114080 : CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV; CAMK4 *114085 : S100 CALCIUM-BINDING PROTEIN A10; S100A10 *114090 : CALPASTATIN; CAST 114100 : CALCIFICATION OF BASAL GANGLIA WITH OR WITHOUT HYPOCALCEMIA *114105 : PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA *114106 : PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB *114107 : PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC *114110 : S100 CALCIUM-BINDING PROTEIN A6; S100A6 114120 : CALCINOSIS, TUMORAL *114130 : CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA *114131 : CALCITONIN RECEPTOR; CALCR *114140 : CALLOSITIES, HEREDITARY PAINFUL *114150 : CAMPTOBRACHYDACTYLY *114160 : CALCITONIN-RELATED POLYPEPTIDE, BETA; CALCB *114170 : CALPAIN, SMALL SUBUNIT 1; CAPNS1 *114180 : CALMODULIN 1; CALM1 *114181 : CALMODULIN-LIKE 1; CALML1 *114182 : CALMODULIN 2; CALM2 *114183 : CALMODULIN 3; CALM3 *114184 : CALMODULIN-LIKE 3; CALML3 *114190 : CALCITONIN RECEPTOR-LIKE GENE; CALCRL *114200 : CAMPTODACTYLY *114204 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1 *114205 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C *114206 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D *114207 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1 *114208 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S *114209 : CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT; CACNG1 *114210 : S100 CALCIUM-BINDING PROTEIN A4; S100A4 *114212 : CALCYPHOSINE; CAPS *114213 : CALDESMON 1; CALD1 *114217 : CALNEXIN; CANX *114220 : CALPAIN 1; CAPN1 *114230 : CALPAIN 2; CAPN2 *114240 : CALPAIN 3; CAPN3 *114250 : CALSEQUESTRIN 1; CASQ1 *114251 : CALSEQUESTRIN 2; CASQ2 ^114260 : MOVED TO 300006 *114280 : CAMPATH-1 ANTIGEN; CDW52 *114290 : CAMPOMELIC DYSPLASIA *114300 : CAMPTODACTYLY, CLEFT PALATE, AND CLUBFOOT *114350 : NUCLEOPORIN, 214-KD; NUP214 #114400 : LYNCH CANCER FAMILY SYNDROME II; LCFS2 114450 : CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE #114480 : BREAST CANCER #114500 : COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS; HNPCC #114550 : HEPATOCELLULAR CARCINOMA *114580 : CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT *114600 : CANINE TEETH, ABSENCE OF UPPER PERMANENT *114610 : CANNABINOID RECEPTOR 1; CNR1 114620 : CANTU SYNDROME 114650 : CAR FACTOR DEFICIENCY 114700 : CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH *114750 : CARBONIC ANHYDRASE III; CA3 *114760 : CARBONIC ANHYDRASE IV; CA4 *114761 : CARBONIC ANHYDRASE V; CA5A *114770 : CARBONIC ANHYDRASE VII; CA7 *114780 : CARBONIC ANHYDRASE VI; CA6 *114800 : CARBONIC ANHYDRASE I; CA1 *114815 : CARBONIC ANHYDRASE VIII; CA8 *114830 : CARBONYL REDUCTASE 1; CBR1 *114835 : CARBOXYLESTERASE 1; CES1 ^114836 : MOVED TO 114835 *114840 : CARBOXYL-ESTER LIPASE; CEL *114841 : CARBOXYL-ESTER LIPASE-LIKE; CELL *114850 : CARBOXYPEPTIDASE A1; CPA1 *114851 : CARBOXYPEPTIDASE A3, MAST CELL; CPA3 *114852 : CARBOXYPEPTIDASE B1, TISSUE; CPB1 *114855 : CARBOXYPEPTIDASE E; CPE *114860 : CARBOXYPEPTIDASE M; CPM *114890 : CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5; CEACAM5 114900 : CARCINOID TUMORS, INTESTINAL 115000 : CARDIAC ARRHYTHMIA #115080 : CARDIAC CONDUCTION DEFECT 115150 : CARDIOFACIOCUTANEOUS SYNDROME #115195 : CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2 #115196 : CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3 #115197 : CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4 115198 : CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 5 #115200 : CARDIOMYOPATHY, DILATED, 1A; CMD1A *115210 : CARDIOMYOPATHY, FAMILIAL RESTRICTIVE 115250 : CARDIOMYOPATHY-HYPOGONADISM-COLLAGENOMA SYNDROME 115300 : CAROTENEMIA, FAMILIAL #115310 : CAROTID BODY TUMORS AND MULTIPLE EXTRAADRENAL PHEOCHROMOCYTOMAS 115400 : CARPAL DISPLACEMENT *115430 : CARPAL TUNNEL SYNDROME; CTS1 *115435 : CARTILAGE LINK PROTEIN; CRTL1 *115437 : MATRILIN 1; MATN1 *115440 : CASEIN KINASE II, ALPHA-1; CSNK2A1 *115441 : CASEIN KINASE II, BETA; CSNK2B *115442 : CASEIN KINASE II, ALPHA-2; CSNK2A2 *115450 : CASEIN, ALPHA; CSN1 *115460 : CASEIN, BETA; CSN2 #115470 : CAT EYE SYNDROME; CES *115500 : CATALASE; CAT *115501 : TYROSINASE-RELATED PROTEIN 1; TYRP1 115645 : CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION *115650 : CATARACT, ANTERIOR POLAR, 1; CTAA1 *115660 : CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1 *115665 : CATARACT, CONGENITAL, VOLKMANN TYPE; CCV #115700 : CATARACT, CRYSTALLINE ACULEIFORM OR FROSTED *115800 : CATARACT, CRYSTALLINE CORALLIFORM *115900 : CATARACT, FLORIFORM 116100 : CATARACT, MEMBRANOUS *116150 : CATARACT-MICROCORNEA SYNDROME #116200 : CATARACT, ZONULAR PULVERULENT 1; CZP1 *116300 : CATARACT, NUCLEAR DIFFUSE NONPROGRESSIVE *116400 : CATARACT, NUCLEAR TOTAL *116600 : CATARACT, POSTERIOR POLAR 1 116700 : CATARACT, TOTAL CONGENITAL; CC *116790 : CATECHOL-O-METHYLTRANSFERASE; COMT #116800 : CATARACT, LAMELLAR *116805 : CATENIN, ALPHA-1; CTNNA1 *116806 : CATENIN, BETA-1; CTNNB1 *116810 : CATHEPSIN B; CTSB *116820 : CATHEPSIN H; CTSH *116830 : CATHEPSIN G; CTSG *116831 : GRANZYME H; GZMH *116840 : CATHEPSIN D; CTSD *116845 : CATHEPSIN S; CTSS 116850 : CATATRICHY #116860 : CEREBRAL CAVERNOUS MALFORMATIONS 1; CCM1 116870 : CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM *116880 : CATHEPSIN L; CTSL *116890 : CATHEPSIN E; CTSE *116896 : CUT-LIKE, 1; CUTL1 *116897 : CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA *116898 : CCAAT/ENHANCER-BINDING PROTEIN, DELTA; CEBPD *116899 : CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A *116900 : CDC2-ASSOCIATED PROTEIN CKS1; CKS1 *116901 : CDC2-ASSOCIATED PROTEIN CKS2; CKS2 #116920 : LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD *116930 : CELL ADHESION MOLECULE, NEURAL, 1; NCAM1 *116935 : CELL MATRIX ADHESION REGULATOR; CMAR *116940 : CELL DIVISION CYCLE 2, G1 TO S AND G2 TO M; CDC2 *116945 : MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 2; MCM2 *116946 : CELL DIVISION CYCLE 27; CDC27 *116947 : CELL DIVISION CYCLE 25A; CDC25A *116948 : CELL DIVISION CYCLE 34; CDC34 *116949 : CELL DIVISION CYCLE 25B; CDC25B *116950 : CELL CYCLE CONTROLLER G1 *116951 : CELL DIVISION CYCLE 2-LIKE 2; CDC2L2 *116952 : CELL DIVISION CYCLE 42; CDC42 *116953 : CYCLIN-DEPENDENT KINASE 2; CDK2 *116954 : ANTIGEN DEFINED BY MONOCLONAL ANTIBODY TRA-2-10; MIC10 *116955 : ZINC FINGER PROTEIN 9; ZNF9 *116957 : RETINOBLASTOMA-LIKE 1; RBL1 *116960 : SENESCENCE-RELATED, CELLULAR, 1; SEN1 #117000 : CENTRAL CORE DISEASE OF MUSCLE *117100 : CENTRALOPATHIC EPILEPSY *117139 : CENTROMERIC PROTEIN A; CENPA *117140 : CENTROMERIC PROTEIN B; CENPB *117141 : CENTROMERIC PROTEIN C1; CENPC1 *117142 : CENTROMERIC PROTEIN D; CENPD *117143 : CENTROMERIC PROTEIN E; CENPE ^117200 : REMOVED FROM DATABASE *117210 : CEREBELLAR ATAXIA, AUTOSOMAL DOMINANT PURE #117300 : DEMENTIA, FAMILIAL DANISH; FDD *117340 : CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2; CDR2 *117350 : CEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS 117360 : CEREBELLAR VERMIS APLASIA *117400 : CEREBELLOPARENCHYMAL DISORDER I; CPD I #117550 : SOTOS SYNDROME 117600 : CEREBRAL SARCOMA 117650 : CEREBROCOSTOMANDIBULAR SYNDROME *117700 : CERULOPLASMIN; CP *117800 : CERUMEN, VARIATION IN 117850 : CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS 117900 : CERVICAL RIB 118000 : CERVICAL VERTEBRAL BRIDGE 118005 : CERVICAL VERTEBRAL DYSPLASIA *118100 : CERVICAL VERTEBRAL FUSION, AUTOSOMAL DOMINANT ^118150 : MOVED TO 107776 *118190 : HEAT-SHOCK 60-KD PROTEIN 1; HSPD1 #118200 : CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B; CMT1B #118210 : CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, A; CMT2A #118220 : CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A 118230 : CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE #118300 : CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS 118301 : CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM 118330 : CHEILITIS GLANDULARIS 118350 : CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS #118400 : CHERUBISM 118420 : CHIARI MALFORMATION TYPE I *118423 : CHIMERIN 1; CHN1 *118425 : CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1 118430 : CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF *118440 : CHOLECYSTOKININ; CCK *118444 : CHOLECYSTOKININ A RECEPTOR; CCKAR *118445 : CHOLECYSTOKININ B RECEPTOR; CCKBR #118450 : ALAGILLE SYNDROME; AGS *118455 : CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1; CYP7A1 *118457 : CHOLESTEROL CRYSTALLIZATION INHIBITOR; CCI *118470 : CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP *118480 : CHOLESTEROL REPRESSIBLE PROTEIN 39B; CHR39B *118485 : CYTOCHROME P450, SUBFAMILY XIA; CYP11A *118490 : CHOLINE ACETYLTRANSFERASE; CHAT *118491 : CHOLINE KINASE; CHK *118493 : CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2 *118494 : CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3 *118495 : CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4 *118496 : CHOLINERGIC RECEPTOR, MUSCARINIC, 5; CHRM5 *118502 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2 *118503 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3; CHRNA3 *118504 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4 *118505 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5; CHRNA5 *118507 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2 *118508 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3; CHRNB3 *118509 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4; CHRNB4 *118510 : CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1 *118511 : CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7; CHRNA7 *118600 : CHONDROCALCINOSIS 2; CCAL2 118610 : CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION *118650 : CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT 118651 : CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE *118661 : CHONDROITIN SULFATE PROTEOGLYCAN 2; CSPG2 118670 : CHONDRONECTIN *118700 : CHOREA, HEREDITARY BENIGN; BCH 118750 : CHOREOATHETOSIS, FAMILIAL INVERTED *118800 : PAROXYSMAL NONKINESIGENIC DYSKINESIA; PNKD *118820 : CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2 *118825 : CHOROIDEREMIA-LIKE; CHML *118830 : CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE *118840 : CHROMATE RESISTANCE; CHR *118850 : CHORIONIC GONADOTROPIN, ALPHA CHAIN; CGA *118860 : CHORIONIC GONADOTROPIN, BETA CHAIN; CGB 118865 : CHOROIDAL OSTEOMA, BILATERAL *118870 : CHROMOSOMAL PROTEIN, NONHISTONE 1; NHCP1 *118880 : CHROMOSOMAL PROTEIN, NONHISTONE 2; NHCP2 *118888 : CHYMOTRYPSIN-LIKE PROTEASE; CTRL *118890 : CHYMOTRYPSINOGEN B1; CTRB1 118900 : CIRRHOSIS, FAMILIAL *118910 : CHROMOGRANIN A; CHGA *118920 : CHROMOGRANIN B; CHGB *118930 : SECRETOGRANIN II; SCG2 *118938 : CHYMASE 1; CMA1 ^118940 : MOVED TO 118938 118943 : CHYMOSIN PSEUDOGENE; CYMP *118945 : CILIARY NEUROTROPHIC FACTOR; CNTF *118946 : CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR *118950 : CITRATE SYNTHASE, MITOCHONDRIAL; CS ^118953 : MOVED TO 192020 *118955 : CLATHRIN, HEAVY POLYPEPTIDE; CLTC *118960 : CLATHRIN, LIGHT POLYPEPTIDE A; CLTA *118970 : CLATHRIN, LIGHT POLYPEPTIDE B; CLTB 118980 : CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL *118990 : SPERM-SPECIFIC ANTIGEN 2; SSFA2 *119000 : CLEFT CHIN *119100 : CLEFT HAND AND ABSENT TIBIA *119300 : VAN DER WOUDE SYNDROME; VWS *119500 : POPLITEAL PTERYGIUM SYNDROME; PPS *119530 : OROFACIAL CLEFT 1; OFC1 *119540 : CLEFT PALATE, ISOLATED; CPI *119550 : CLEFT PALATE-LATERAL SYNECHIA SYNDROME 119570 : CLEFT SOFT PALATE 119580 : BLEPHAROCHEILODONTIC SYNDROME #119600 : CLEIDOCRANIAL DYSPLASIA; CCD 119650 : CLEIDORHIZOMELIC SYNDROME 119800 : CLUBFOOT *119900 : CLUBBING OF DIGITS 119915 : CLUSTER HEADACHE, FAMILIAL 120000 : COARCTATION OF AORTA 120040 : COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS *120050 : COXSACKIE B3 VIRUS SUSCEPTIBILITY; CXB3S *120070 : COLLAGEN, TYPE IV, ALPHA-3; COL4A3 #120080 : COLCHICINE RESISTANCE *120090 : COLLAGEN, TYPE IV, ALPHA-2; COL4A2 #120100 : FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FCAS *120105 : COLIPASE, PANCREATIC; CLPS *120110 : COLLAGEN, TYPE X, ALPHA-1; COL10A1 *120120 : COLLAGEN, TYPE VII, ALPHA-1; COL7A1 *120130 : COLLAGEN, TYPE IV, ALPHA-1; COL4A1 *120131 : COLLAGEN, TYPE IV, ALPHA-4; COL4A4 *120140 : COLLAGEN, TYPE II, ALPHA-1; COL2A1 *120150 : COLLAGEN, TYPE I, ALPHA-1; COL1A1 *120160 : COLLAGEN, TYPE I, ALPHA-2; COL1A2 *120165 : COLLAGEN, TYPE XIX, ALPHA-1; COL19A1 *120170 : COLLAGEN, FETAL MEMBRANE, B POLYPEPTIDE *120180 : COLLAGEN, TYPE III, ALPHA-1; COL3A1 *120190 : COLLAGEN, TYPE V, ALPHA-2; COL5A2 *120200 : COLOBOMA OF IRIS, CHOROID AND RETINA; COI *120210 : COLLAGEN, TYPE IX, ALPHA-1; COL9A1 *120215 : COLLAGEN, TYPE V, ALPHA-1; COL5A1 *120216 : COLLAGEN, TYPE V, ALPHA-3; COL5A3 *120220 : COLLAGEN, TYPE VI, ALPHA-1; COL6A1 *120240 : COLLAGEN, TYPE VI, ALPHA-2; COL6A2 *120250 : COLLAGEN, TYPE VI, ALPHA-3; COL6A3 *120251 : COLLAGEN, TYPE VIII, ALPHA-1; COL8A1 *120252 : COLLAGEN, TYPE VIII, ALPHA-2; COL8A2 *120260 : COLLAGEN, TYPE IX, ALPHA-2; COL9A2 *120270 : COLLAGEN, TYPE IX, ALPHA-3; COL9A3 *120280 : COLLAGEN, TYPE XI, ALPHA-1; COL11A1 *120290 : COLLAGEN, TYPE XI, ALPHA-2; COL11A2 *120300 : COLOBOMA OF MACULA ^120310 : MOVED TO 120140 *120320 : COLLAGEN, TYPE XII, ALPHA-1; COL12A1 *120321 : COLLAGEN, TYPE XII, ALPHA 1-LIKE *120324 : COLLAGEN, TYPE XIV, ALPHA-1; COL14A1 *120325 : COLLAGEN, TYPE XV, ALPHA-1; COL15A1 *120326 : COLLAGEN, TYPE XVI, ALPHA-1; COL16A1 ^120327 : MOVED TO 113811 *120328 : COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1 #120330 : RENAL-COLOBOMA SYNDROME *120340 : COLLAGEN, TYPE I, ALPHA, RECEPTOR; COL1AR *120350 : COLLAGEN, TYPE XIII, ALPHA-1; COL13A1 *120353 : MATRIX METALLOPROTEINASE 1; MMP1 *120355 : MATRIX METALLOPROTEINASE 8; MMP8 *120360 : MATRIX METALLOPROTEINASE 2; MMP2 *120361 : MATRIX METALLOPROTEINASE 9; MMP9 120400 : COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY *120420 : COLONY-STIMULATING FACTOR 1; CSF1 120430 : COLOBOMA OF OPTIC NERVE 120433 : COLOBOMA, UVEAL, WITH CLEFT LIP AND PALATE AND MENTAL RETARDATION *120435 : COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1 *120436 : COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2 120440 : COLONIC VARICES WITHOUT PORTAL HYPERTENSION *120450 : COMEDONES, FAMILIAL DYSKERATOTIC ^120460 : MOVED TO 191170 *120470 : DELETED IN COLORECTAL CARCINOMA; DCC 120500 : COMMISSURAL LIP PITS *120502 : BRANCHIOOTIC SYNDROME 2 *120520 : MEMBRANE METALLOENDOPEPTIDASE; MME *120550 : COMPLEMENT COMPONENT 1, q SUBCOMPONENT, ALPHA POLYPEPTIDE; C1QA *120560 : COMPLEMENT COMPONENT C1q, FIBROBLAST TYPE *120570 : COMPLEMENT COMPONENT 1, q SUBCOMPONENT, BETA POLYPEPTIDE; C1QB *120575 : COMPLEMENT COMPONENT 1, q SUBCOMPONENT, GAMMA POLYPEPTIDE; C1QG *120577 : COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1 *120580 : COMPLEMENT COMPONENT 1, s SUBCOMPONENT; C1S *120620 : COMPLEMENT COMPONENT RECEPTOR 1; CR1 *120650 : COMPLEMENT COMPONENT RECEPTOR 2; CR2 *120700 : COMPLEMENT COMPONENT 3; C3 #120790 : COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF *120810 : COMPLEMENT COMPONENT 4A; C4A *120820 : COMPLEMENT COMPONENT 4B; C4B *120830 : COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA; C4BPA *120831 : COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN; C4BPB ^120832 : MOVED TO 120830 *120900 : COMPLEMENT COMPONENT 5 DEFICIENCY *120920 : MEMBRANE COFACTOR PROTEIN; MCP *120930 : COMPLEMENT COMPONENT 8, GAMMA SUBUNIT; C8G *120940 : COMPLEMENT COMPONENT 9; C9 *120950 : COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I *120960 : COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II #120970 : CONE-ROD DYSTROPHY 2; CORD2 *120980 : INTEGRIN, ALPHA-M; ITGAM ^121000 : REMOVED FROM DATABASE *121009 : CONNECTIVE TISSUE GROWTH FACTOR; CTGF *121010 : PRO-PLATELET BASIC PROTEIN; PPBP *121011 : GAP JUNCTION PROTEIN, BETA-2; GJB2 *121012 : GAP JUNCTION PROTEIN, ALPHA-4; GJA4 *121013 : GAP JUNCTION PROTEIN, ALPHA-5; GJA5 *121014 : GAP JUNCTION PROTEIN, ALPHA-1; GJA1 *121015 : GAP JUNCTION PROTEIN, ALPHA-3; GJA3 121020 : CONTINUOUS MUSCLE FIBER ACTIVITY, HEREDITARY *121050 : CONTRACTURAL ARACHNODACTYLY, CONGENITAL 121070 : CONTRACTURES OF FINGERS AND JAW #121200 : EPILEPSY, BENIGN NEONATAL, 1; EBN1 #121201 : EPILEPSY, BENIGN NEONATAL, 2; EBN2 #121210 : FEBRILE SEIZURES ^121250 : MOVED TO 300088 121270 : COPPER DEFICIENCY, FAMILIAL BENIGN *121300 : COPROPORPHYRIA 121350 : CORACOCLAVICULAR JOINT, ANOMALOUS *121360 : CORE-BINDING FACTOR, BETA SUBUNIT; CBFB *121390 : CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS *121400 : CORNEA PLANA 1; CNA1 121450 : CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS *121700 : CORNEAL ENDOTHELIAL DYSTROPHY 1; CHED1 *121800 : CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER 121820 : CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE *121850 : CORNEAL DYSTROPHY, FRANCOIS-NEETENS SPECKLED OR FLECKED #121900 : CORNEAL DYSTROPHY, GRANULAR TYPE #122000 : CORNEAL DYSTROPHY, HEREDITARY POLYMORPHOUS POSTERIOR #122100 : CORNEAL DYSTROPHY, JUVENILE EPITHELIAL, OF MEESMANN #122200 : CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1 *122400 : CORNEAL EROSIONS, RECURRING HEREDITARY 122430 : CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION 122440 : CORNEODERMATOOSSEOUS SYNDROME *122450 : CORNEAL HYPESTHESIA, FAMILIAL 122455 : CORONARY ARTERY DISSECTION, SPONTANEOUS *122460 : CORONAVIRUS 229E SUSCEPTIBILITY; CVS 122470 : CORNELIA DE LANGE SYNDROME 1; CDL1 ^122480 : MOVED TO 166740 *122500 : CORTICOSTEROID-BINDING GLOBULIN; CBG 122550 : CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI *122559 : CORTICOTROPIN RELEASING HORMONE-BINDING PROTEIN; CRHBP *122560 : CORTICOTROPIN-RELEASING HORMONE; CRH *122561 : CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1 122580 : COSTOCORACOID LIGAMENT, CONGENITALLY SHORT *122600 : COSTOVERTEBRAL SEGMENTATION ANOMALIES #122700 : COUMARIN RESISTANCE *122720 : CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6 *122750 : COXA VARA 122780 : COXOAURICULAR SYNDROME 122850 : CRANIOACROFACIAL SYNDROME 122860 : CRANIODIAPHYSEAL DYSPLASIA, DOMINANT #122880 : CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS 122900 : CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA 122920 : CRANIOFRONTAL DYSPLASIA #123000 : CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD 123050 : CRANIORHINY *123100 : CRANIOSYNOSTOSIS, TYPE 1; CRS1 *123101 : MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 2; MSX2 #123150 : JACKSON-WEISS SYNDROME; JWS 123155 : CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS *123260 : C-REACTIVE PROTEIN, PENTRAXIN-RELATED; CRP 123270 : CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE *123280 : CREATINE KINASE, BRAIN TYPE; CKB *123290 : CREATINE KINASE, MITOCHONDRIAL; CKMT *123295 : CREATINE KINASE, SARCOMERIC MITOCHONDRIAL; CKMTS *123310 : CREATINE KINASE, MUSCLE TYPE; CKM #123320 : CREATINE PHOSPHOKINASE, ELEVATED SERUM #123400 : CREUTZFELDT-JAKOB DISEASE; CJD #123450 : CRI-DU-CHAT SYNDROME #123500 : CROUZON SYNDROME 123540 : CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY *123550 : CRYOGLOBULINEMIA, FAMILIAL MIXED *123555 : CRYPTDIN-RELATED SEQUENCE 1C; CRS1C 123557 : CRYPTOTIA, FAMILIAL 123560 : CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME *123570 : CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED *123580 : CRYSTALLIN, ALPHA-A; CRYAA *123590 : CRYSTALLIN, ALPHA-B; CRYAB *123610 : CRYSTALLIN, BETA-A1; CRYBA1 *123620 : CRYSTALLIN, BETA-B2; CRYBB2 *123630 : CRYSTALLIN, BETA-B3; CRYBB3 *123631 : CRYSTALLIN, BETA-A4; CRYBA4 *123660 : CRYSTALLIN, GAMMA-A; CRYGA *123670 : CRYSTALLIN, GAMMA-B; CRYGB *123680 : CRYSTALLIN, GAMMA-C; CRYGC *123690 : CRYSTALLIN, GAMMA-D; CRYGD *123691 : CRYSTALLIN, ZETA; CRYZ *123695 : PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM; PCYT1A #123700 : CUTIS LAXA ^123710 : MOVED TO 123660 ^123720 : MOVED TO 123660 *123730 : CRYSTALLIN, GAMMA-S; CRYGS *123740 : CRYSTALLIN, MU; CRYM #123790 : CUTIS GYRATA SYNDROME OF BEARE AND STEVENSON *123803 : ACTIVATING TRANSCRIPTION FACTOR 1; ATF1 *123805 : PHOSPHODIESTERASE 3A, cGMP-INHIBITED; PDE3A *123810 : cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1 *123811 : ACTIVATING TRANSCRIPTION FACTOR 2; ATF2 *123812 : cAMP RESPONSE ELEMENT MODULATOR; CREM *123825 : CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1; CNGA1 *123828 : CYCLIN-DEPENDENT KINASE 3; CDK3 *123829 : CYCLIN-DEPENDENT KINASE 4; CDK4 *123830 : CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CNP *123831 : CYCLIN-DEPENDENT KINASE 5; CDK5 *123832 : CYCLIN-DEPENDENT KINASE INHIBITOR 3; CDKN3 *123833 : CYCLIN D2; CCND2 *123834 : CYCLIN D3; CCND3 *123835 : CYCLIN A2; CCNA2 *123836 : CYCLIN B1; CCNB1 *123837 : CYCLIN E1; CCNE1 *123838 : CYCLIN C; CCNC ^123839 : MOVED TO 600262 *123840 : PEPTIDYL-PROLYL ISOMERASE A; PPIA *123841 : PEPTIDYL-PROLYL ISOMERASE B; PPIB *123842 : PEPTIDYL-PROLYL ISOMERASE C; PPIC ^123850 : MOVED TO 132700 123853 : CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME *123855 : CYSTATIN 1; CST1 *123856 : CYSTATIN 2; CST2 *123857 : CYSTATIN 4; CST4 *123858 : CYSTATIN 5; CST5 *123859 : CYSTEINYL-tRNA SYNTHETASE; CARS *123860 : CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE; CTPS *123864 : CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 1; COX4I1 *123866 : CYTOCHROME c OXIDASE, SUBUNIT Vb; COX5B *123870 : CYTOCHROME c OXIDASE, SUBUNIT VIII; COX8 *123875 : CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1 *123876 : CYSTEINE- AND GLYCINE-RICH PROTEIN 1; CSRP1 123880 : CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE *123885 : S100 CALCIUM-BINDING PROTEIN A8; S100A8 *123886 : S100 CALCIUM-BINDING PROTEIN A9; S100A9 *123889 : INTERLEUKIN 10 RECEPTOR, BETA; IL10RB *123890 : CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4 *123900 : VILLIN 2; VIL2 *123910 : GRANZYME B; GZMB *123920 : CYTIDINE DEAMINASE; CDA *123930 : CYTOCHROME P450, SUBFAMILY IIB; CYP2B *123940 : KERATIN 4; KRT4 ^123950 : MOVED TO 250790 *123960 : CYTOCHROME P450, SUBFAMILY IIA; CYP2A *123970 : CYTOCHROME C *123980 : CYTOCHROME C1; CYC1 *123995 : CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 1; COX7A1 *123996 : CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 2; COX7A2 *123997 : CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 3; COX7A3 124000 : CYTOCHROME-RELATED DISEASE OF MUSCLE AND NERVOUS SYSTEM *124010 : CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4 *124015 : CYTOCHROME P-450 REDUCTASE; POR *124020 : CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 *124030 : CYTOCHROME P450, SUBFAMILY IID; CYP2D *124040 : CYTOCHROME P450, SUBFAMILY IIE; CYP2E *124050 : D-AMINO ACID OXIDASE; DAO *124060 : CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2 *124070 : CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1; CYP2F1 *124075 : CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1; CYP4B1 *124080 : CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2 *124089 : CYTOCHROME c OXIDASE, SUBUNIT VIb; COX6B *124090 : CYTOCHROME c OXIDASE, SUBUNIT VIc; COX6C *124092 : INTERLEUKIN 10; IL10 *124095 : CYTOPLASMIC TYROSINE KINASE; CSK *124097 : D SITE OF ALBUMIN PROMOTER-BINDING PROTEIN; DBP 124100 : DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY #124200 : DARIER-WHITE DISEASE; DAR 124300 : DARWINIAN POINT OF PINNA 124400 : DARWINIAN TUBERCLE OF PINNA *124450 : D-ASPARTATE OXIDASE *124480 : DEAFNESS AND ONYCHODYSTROPHY, DOMINANT FORM 124490 : DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY #124500 : DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES ^124580 : REMOVED FROM DATABASE *124700 : DEAFNESS, MID-TONE NEURAL *124800 : DEAFNESS, PROGRESSIVE HIGH-TONE NEURAL #124900 : DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 1; DFNA1 124910 : DEAFNESS: LOW-FREQUENCY HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL TYPE 124950 : DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE 125000 : DEAFNESS, UNILATERAL 125050 : DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA 125100 : DEAFNESS WITH EAR PITS *125220 : DEFENSIN, ALPHA, 1; DEFA1 125230 : DEAFNESS-CRANIOFACIAL SYNDROME *125240 : DECAY-ACCELERATING FACTOR FOR COMPLEMENT; DAF 125250 : DEAFNESS--OPTIC ATROPHY SYNDROME *125255 : DECORIN; DCN *125260 : DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF *125263 : SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1; SULT2A1 *125264 : DEK ONCOGENE; DEK *125265 : DELETED IN POLYPOSIS 1 *125270 : DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD 125280 : DENS EVAGINATUS *125290 : DELTA-AMINOLEVULINATE SYNTHASE; ALAS1 125300 : DENS IN DENTE AND PALATAL INVAGINATIONS *125305 : ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49 #125310 : CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CADASIL 125320 : DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES 125350 : DENTAL NONERUPTION *125370 : DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA *125400 : DENTIN DYSPLASIA, TYPE I *125420 : DENTIN DYSPLASIA, TYPE II *125440 : DENTIN DYSPLASIA WITH SCLEROTIC BONES *125450 : DEOXYCYTIDINE KINASE; DCK 125460 : DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY *125480 : MAJOR AFFECTIVE DISORDER 1; MAFD1 *125485 : DENTIN SIALOPHOSPHOPROTEIN; DSPP #125490 : DENTINOGENESIS IMPERFECTA 1; DGI1 125500 : DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III *125505 : DEOXYRIBONUCLEASE I; DNASE1 ^125510 : REMOVED FROM DATABASE *125520 : DEPRESSOR ANGULI ORIS MUSCLE, HYPOPLASIA OF 125530 : DERMAL RIDGES, NELSON SYNDROME *125540 : DERMAL RIDGES, PATTERNLESS *125550 : DERMAL RIDGES-OFF-THE-END 125570 : DERMATOGLYPHICS--ARCH ON ANY DIGIT 125580 : DERMATOGLYPHICS--FINGER RIDGE COUNT 125590 : DERMATOGLYPHICS--FINGERPRINT PATTERN 125595 : DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR *125597 : DERMATOPONTIN; DPT 125600 : DERMATOSIS PAPULOSA NIGRA 125630 : DERMODISTORTIVE URTICARIA; DDU 125635 : DERMOGRAPHISM, FAMILIAL 125640 : DERMOODONTODYSPLASIA *125643 : DESMOCOLLIN 1; DSC1 *125645 : DESMOCOLLIN 2; DSC2 *125647 : DESMOPLAKIN; DSP *125650 : DESMOSTEROL-TO-CHOLESTEROL ENZYME; DCE *125660 : DESMIN; DES *125670 : DESMOGLEIN 1; DSG1 *125671 : DESMOGLEIN 2; DSG2 #125700 : DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE #125800 : DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL DOMINANT #125850 : MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1 #125851 : MATURITY-ONSET DIABETES OF THE YOUNG, TYPE II; MODY2 *125852 : DIABETES MELLITUS, INSULIN-DEPENDENT, 2 #125853 : DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM *125855 : DIACYLGLYCEROL KINASE, ALPHA, 80-KD; DGKA *125860 : NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1 *125870 : DIAPHORASE 2; DIA2 *125880 : DIAPHORASE 3; DIA3 125890 : DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY 125900 : DIASTEMA, DENTAL MEDIAL *125950 : DIAZEPAM BINDING INHIBITOR; DBI *126050 : DIGITOTALAR DYSMORPHISM *126060 : DIHYDROFOLATE REDUCTASE; DHFR ^126061 : MOVED TO 126060 *126063 : DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE; DLST *126064 : DIHYDROOROTATE DEHYDROGENASE; DHODH *126065 : CYTOCHROME P450, SUBFAMILY XXIV; CYP24 *126070 : DILUTION, PIGMENTARY *126090 : PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE; PCBD 126100 : DIMPLES, FACIAL *126110 : ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT ^126140 : MOVED TO 102720 *126141 : DIPEPTIDYL PEPTIDASE IV-RELATED PROTEIN; DPPX *126150 : DIPHTHERIA TOXIN RECEPTOR; DTR 126180 : DISCRIMINATION, TWO-POINT, REDUCTION IN 126190 : DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS #126200 : MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS 126250 : DISTAL OSTEOSCLEROSIS *126255 : DISTAL-LESS HOMEO BOX 2; DLX2 *126300 : DISTICHIASIS 126320 : DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE *126330 : DNA, CYTOPLASMIC-MEMBRANE; DNCM *126335 : GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, ALPHA; GADD45A *126337 : DNA DAMAGE-INDUCIBLE TRANSCRIPT 3; DDIT3 *126340 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2 *126350 : DEOXYRIBONUCLEASE II, LYSOSOMAL; DNASE2 126370 : DNA, SATELLITE, III; HS3; D1Z1 *126375 : DNA METHYLTRANSFERASE 1; DNMT1 *126380 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; ERCC1 126390 : DNA, LOW-REPETITIVE SEQUENCES OF *126391 : LIGASE I, DNA, ATP-DEPENDENT; LIG1 126410 : DNA, SATELLITE, ALPHA TYPE *126420 : TOPOISOMERASE, DNA, I; TOP1 *126430 : TOPOISOMERASE, DNA, II, ALPHA; TOP2A *126431 : TOPOISOMERASE, DNA, II, BETA; TOP2B ^126440 : REMOVED FROM DATABASE ^126448 : MOVED TO 126453 *126449 : DOPAMINE RECEPTOR D1; DRD1 *126450 : DOPAMINE RECEPTOR D2; DRD2 *126451 : DOPAMINE RECEPTOR D3; DRD3 *126452 : DOPAMINE RECEPTOR D4; DRD4 *126453 : DOPAMINE RECEPTOR D5; DRD5 *126455 : SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3; SLC6A3 126500 : DOUBLE NAIL FOR FIFTH TOE *126550 : DOUGHNUT LESIONS OF SKULL, FAMILIAL #126600 : DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD *126650 : SOLUTE CARRIER FAMILY 26, MEMBER 3; SLC26A3 *126660 : DREBRIN E; DBN1 126700 : DRUSEN OF BRUCH MEMBRANE *126800 : DUANE RETRACTION SYNDROME 1; DURS1 ^126830 : MOVED TO 169100 126840 : DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION *126850 : DUODENAL ULCER, HYPERPEPSINOGENEMIC I *126900 : DUPUYTREN CONTRACTURE 126950 : DWARFISM WITH TALL VERTEBRAE *127000 : KENNY-CAFFEY SYNDROME, TYPE 2 127100 : DWARFISM, LEVI TYPE 127200 : DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES #127300 : LERI-WEILL DYSCHONDROSTEOSIS; LWD 127350 : DYSCHONDROSTEOSIS AND NEPHRITIS *127400 : DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH 127500 : DYSCHROMATOSIS UNIVERSALIS HEREDITARIA #127550 : DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT *127600 : DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL *127700 : DYSLEXIA, SPECIFIC, 1; DYX1 127750 : DEMENTIA, LEWY BODY 127800 : DYSPLASIA EPIPHYSEALIS HEMIMELICA 127820 : DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS *128000 : DYSTELEPHALANGY #128100 : TORSION DYSTONIA 1, AUTOSOMAL DOMINANT; DYT1 *128101 : DYSTONIA MUSCULORUM DEFORMANS 4; DYT4 *128200 : PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC #128230 : DYSTONIA, PROGRESSIVE, WITH DIURNAL VARIATION *128235 : DYSTONIA 12; DYT12 *128239 : DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1 *128240 : UTROPHIN; UTRN *128260 : SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E; SNRPE 128290 : EAR ANTITRAGUS, TAG AT BASE OF 128300 : EAR EXOSTOSES 128400 : EAR FLARE 128500 : EAR FOLDING *128600 : EAR MALFORMATION *128700 : EAR PITS 128710 : EAR PITS, POSTERIOR HELICAL 128800 : EAR WITHOUT HELIX 128900 : EARLOBE ATTACHMENT: ATTACHED VS UNATTACHED 128950 : EARLOBE CREASE *128980 : EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES *128990 : EARLY GROWTH RESPONSE 1; EGR1 *128992 : EARLY GROWTH RESPONSE 4; EGR4 129000 : EARRING HOLES, NATURAL *129010 : EARLY GROWTH RESPONSE 2; EGR2 129100 : EARS, ABILITY TO MOVE *129150 : ECHO 11 SENSITIVITY; E11S *129190 : NUCLEOTIDASE, ECTO-5-PRIME; NT5E *129200 : ECTODERMAL DYSPLASIA, ABSENT DERMATOGLYPHIC PATTERN, CHANGES IN NAILS, AND SIMIAN CREASE *129400 : ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP AND CLEFT PALATE #129490 : ECTODERMAL DYSPLASIA 3, ANHIDROTIC; ED3 #129500 : ECTODERMAL DYSPLASIA 2, HIDROTIC; ED2 129510 : ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE 129540 : ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET 129550 : ECTODERMAL DYSPLASIA WITH ADRENAL CYST *129600 : ECTOPIA LENTIS, ISOLATED #129750 : ECTOPIA PUPILLAE 129810 : ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE 129830 : ECTRODACTYLY-CLEFT PALATE SYNDROME 129840 : EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL #129850 : EDINBURGH MALFORMATION SYNDROME *129900 : ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1 129905 : EGASYN #130000 : EHLERS-DANLOS SYNDROME, TYPE I; EDS1 #130010 : EHLERS-DANLOS SYNDROME, TYPE II; EDS2 #130020 : EHLERS-DANLOS SYNDROME, TYPE III #130050 : EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT; EDS4 #130060 : EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT #130070 : EHLERS-DANLOS SYNDROME, PROGEROID FORM *130080 : EHLERS-DANLOS SYNDROME, TYPE VIII 130090 : EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED 130100 : ELASTOSIS PERFORANS SERPIGINOSA; EPS *130120 : ELASTASE 1; ELA1 *130130 : ELASTASE 2; ELA2 *130135 : PROTEASE INHIBITOR 2, MONOCYTE/NEUTROPHIL DERIVED; ELANH2 *130160 : ELASTIN; ELN *130180 : ELECTROENCEPHALOGRAM, LOW-VOLTAGE #130190 : ELECTROENCEPHALOGRAPHIC PATTERNS; EEG 130200 : ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON 130300 : ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS 130400 : ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES *130410 : ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB *130500 : ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41 *130590 : EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1 *130591 : EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-1; EEF1B1 *130592 : EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA; EEF1D *130593 : EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA; EEF1G #130600 : ELLIPTOCYTOSIS, RHESUS-UNLINKED TYPE *130610 : EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2 *130620 : RIBOSOMAL PROTEIN S14; RPS14 #130650 : BECKWITH-WIEDEMANN SYNDROME; BWS *130660 : EMILIN 130700 : EMPHYSEMA, HEREDITARY PULMONARY 130710 : EMPHYSEMA, CONGENITAL LOBAR; CLE 130720 : EMPTY SELLA TURCICA, PRIMARY, WITH GENERALIZED DYSPLASIA 130900 : ENAMEL HYPOPLASIA, HEREDITARY LOCALIZED 130950 : ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD *131100 : MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1 *131150 : ENDOGENOUS RETROVIRAL SEQUENCE 1; ERV1 *131170 : ENDOGENOUS RETROVIRAL SEQUENCE 3; ERV3 *131180 : ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2; ERPL2 *131190 : ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1; ERPL1 *131195 : ENDOGLIN; ENG 131200 : ENDOMETRIOSIS *131210 : SELECTIN E; SELE *131220 : FIBROBLAST GROWTH FACTOR 1; FGF1 *131222 : ENDOTHELIAL CELL GROWTH FACTOR, PLATELET-DERIVED; ECGF1 *131230 : ANNEXIN A5; ANXA5 *131235 : ENDOPLASMIC RETICULUM KDEL RECEPTOR *131240 : ENDOTHELIN 1; EDN1 *131241 : ENDOTHELIN 2; EDN2 *131242 : ENDOTHELIN 3; EDN3 *131243 : ENDOTHELIN RECEPTOR, TYPE A; EDNRA *131244 : ENDOTHELIN RECEPTOR, TYPE B; EDNRB *131290 : ENGRAILED 1; EN1 #131300 : CAMURATI-ENGELMANN DISEASE *131310 : ENGRAILED 2; EN2 *131320 : GATA-BINDING PROTEIN 3; GATA3 *131330 : PROENKEPHALIN; PENK *131340 : PRODYNORPHIN; PDYN *131360 : ENOLASE 2; ENO2 *131370 : ENOLASE 3; ENO3 131375 : ENOLASE, SPERM SPECIFIC; ENO4 *131390 : NIDOGEN; NID *131398 : RIBONUCLEASE A FAMILY, 3; RNASE3 *131399 : EOSINOPHIL PEROXIDASE; EPX *131400 : EOSINOPHILIA, FAMILIAL *131410 : RIBONUCLEASE A FAMILY, 2; RNASE2 131430 : EOSINOPHILOPENIA 131440 : EOSINOPHILS, MALIGNANT PROLIFERATION OF 131445 : EPENDYMOMA, FAMILIAL 131450 : EPIBLEPHARON OF LOWER LID 131460 : EPIBLEPHARON OF UPPER LID *131500 : EPICANTHUS *131530 : EPIDERMAL GROWTH FACTOR; EGF *131550 : EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR *131560 : FLOTILLIN 2; FLOT2 131600 : EPIDERMOID CYSTS #131705 : TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN #131750 : EPIDERMOLYSIS BULLOSA DYSTROPHICA, PASINI TYPE #131760 : EPIDERMOLYSIS BULLOSA HERPETIFORMIS, DOWLING-MEARA TYPE #131800 : EPIDERMOLYSIS BULLOSA OF HANDS AND FEET #131850 : EPIDERMOLYSIS BULLOSA, PRETIBIAL 131880 : EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE #131900 : EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE; EBS2 *131950 : EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE #131960 : EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP #132000 : EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS 132090 : EPILEPSY, BENIGN OCCIPITAL; BOE 132100 : EPILEPSY, PHOTOGENIC 132300 : EPILEPSY, READING *132350 : EPIMORPHIN; EPIM #132400 : EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1 #132450 : EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS 132500 : EPISTAXIS, HEREDITARY #132600 : PILOMATRIXOMA #132700 : CYLINDROMATOSIS, FAMILIAL; CYLD *132800 : MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA; MSSE *132810 : EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1 *132811 : EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2 132850 : EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1 132860 : EPSTEIN-BARR VIRUS MODIFICATION SITE 1; EBVM1 *132880 : NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6 *132890 : NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1 #132900 : AORTIC ANEURYSM, THORACIC 132990 : ERYTHEMA NODOSUM, FAMILIAL *133000 : ERYTHEMA PALMARE HEREDITARIUM *133020 : ERYTHERMALGIA, FAMILIAL PRIMARY *133090 : ERYTHROCYTE SURFACE PROTEIN BAND 7.2; EPB72 #133100 : ERYTHROCYTOSIS, FAMILIAL *133170 : ERYTHROPOIETIN; EPO *133171 : ERYTHROPOIETIN RECEPTOR; EPOR 133180 : ERYTHROLEUKEMIA, FAMILIAL *133190 : ERYTHROKERATODERMIA WITH ATAXIA #133200 : ERYTHROKERATODERMIA VARIABILIS; EKV *133220 : ESTERASE A-4; ESA4 *133230 : ESTERASE A-5; ESA5 #133239 : ESOPHAGEAL CANCER 133240 : ESOPHAGEAL RING, LOWER *133250 : ESTERASE ACTIVATOR; ESAT 133260 : ESTERASE B; ESB 133270 : ESTERASE C; ESC *133280 : ESTERASE D; ESD *133290 : ESTERASE B3; ESB3 133300 : ESTERASE ES-2, REGULATOR FOR ^133420 : MOVED TO 113710 *133430 : ESTROGEN RECEPTOR 1; ESR1 *133435 : CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 1; CBFA2T1 *133440 : EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E *133450 : EWING SARCOMA BREAKPOINT REGION 1; EWSR1 *133500 : EXCHONDROSIS OF PINNA, POSTERIOR *133510 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3 *133520 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; ERCC4 *133530 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5 *133535 : EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN MOUSE CELLS; ERCM1 *133540 : EXCISION-REPAIR CROSS-COMPLEMENTING RODENT REPAIR DEFICIENCY, COMPLEMENTATION GROUP 6; ERCC6 *133550 : SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1; SLC1A1 133600 : EXOSTOSES OF HEEL 133690 : EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E *133700 : EXOSTOSES, MULTIPLE, TYPE I *133701 : EXOSTOSES, MULTIPLE, TYPE II; EXT2 133705 : EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS ^133710 : REMOVED FROM DATABASE ^133730 : REMOVED FROM DATABASE ^133740 : REMOVED FROM DATABASE 133750 : EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY *133780 : EXUDATIVE VITREORETINOPATHY, FAMILIAL; EVR 133800 : EYEBROW, WHORL IN 133900 : FACIAL ASYMMETRY 134000 : FACIAL HYPERTRICHOSIS 134100 : FACIAL PALSY, CONGENITAL UNILATERAL OR BILATERAL *134200 : FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL 134300 : FACIAL SPASM *134350 : FACTOR D *134370 : H FACTOR 1; HF1 *134371 : FACTOR H-RELATED GENE 1; FHR1 *134390 : FACTOR III, COAGULATION; F3 134400 : FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS 134430 : FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF *134450 : FACTOR VII REGULATOR; F7R 134500 : FACTOR VIII DEFICIENCY 134510 : FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF 134520 : FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF 134530 : FACTOR X, QUANTITATIVE VARIATION IN 134540 : FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF *134570 : FACTOR XIII, A1 SUBUNIT; F13A1 *134580 : FACTOR XIII, B SUBUNIT; F13B *134600 : FANCONI RENOTUBULAR SYNDROME *134610 : FAMILIAL MEDITERRANEAN FEVER-LIKE SYNDROME WITH AMYLOIDOSIS, AUTOSOMAL DOMINANT *134629 : FARNESYL DIPHOSPHATE SYNTHASE; FDPS *134631 : FARNESYL DIPHOSPHATE SYNTHASE-LIKE 1; FDPSL1 134632 : FARNESYL DIPHOSPHATE SYNTHASE-LIKE 2; FDPSL2 134633 : FARNESYLPYROPHOSPHATE SYNTHETASE 3; FPSL3 134634 : FARNESYLPYROPHOSPHATE SYNTHETASE 4; FPSL4 *134635 : FARNESYLTRANSFERASE, CAAX BOX, ALPHA; FNTA *134636 : FARNESYLTRANSFERASE, CAAX BOX, BETA; FNTB *134637 : TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6; TNFRSF6 *134638 : TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6; TNFSF6 *134640 : FATTY ACID-BINDING PROTEIN 2; FABP2 *134650 : FATTY ACID-BINDING PROTEIN 1; FABP1 *134651 : FATTY ACID-BINDING PROTEIN 3; FABP3 *134660 : GLUTATHIONE S-TRANSFERASE, PI; GSTP1 *134690 : FAU GENE; FAU 134700 : FAVISM, SUSCEPTIBILITY TO 134720 : FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF 134750 : FELTY SYNDROME *134770 : FERRITIN HEAVY CHAIN 1; FTH1 134780 : FEMORAL-FACIAL SYNDROME; FFS *134790 : FERRITIN LIGHT CHAIN; FTL *134795 : FIBRILLARIN; FBL *134797 : FIBRILLIN 1; FBN1 *134820 : FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA *134830 : FIBRINOGEN, B BETA POLYPEPTIDE; FGB *134850 : FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG 134900 : FIBRINOLYTIC DEFECT *134920 : FIBROBLAST GROWTH FACTOR 2; FGF2 *134921 : FIBROBLAST GROWTH FACTOR 6; FGF6 *134934 : FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 *134935 : FIBROBLAST GROWTH FACTOR RECEPTOR 4; FGFR4 *135000 : FIBROCYSTIC PULMONARY DYSPLASIA *135100 : FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP *135150 : BIRT-HOGG-DUBE SYNDROME; BHD #135290 : DESMOID DISEASE, HEREDITARY #135300 : FIBROMATOSIS, GINGIVAL, 1; GINGF 135400 : FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS *135500 : FIBROMATOSIS, GINGIVAL, WITH ABNORMAL FINGERS, FINGERNAILS, NOSE AND EARS, AND SPLENOMEGALY *135550 : FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS 135580 : FIBROMUSCULAR DYSPLASIA OF ARTERIES *135600 : FIBRONECTIN 1; FN1 135610 : FIBRONECTIN-LIKE 2; FNL2 *135620 : INTEGRIN, ALPHA-5; ITGA5 *135630 : INTEGRIN, BETA-1; ITGB1 ^135631 : MOVED TO 135630 *135700 : FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; FEOM1 135750 : FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUS 135800 : FIBULA, RECURRENT DISLOCATION OF HEAD OF *135820 : FIBULIN 1; FBLN1 *135821 : FIBULIN 2; FBLN2 135900 : FIFTH DIGIT SYNDROME *135940 : FILAGGRIN; FLG 135950 : FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE *136000 : FINGERPRINTS, ABSENCE OF 136100 : FINGERS, RELATIVE LENGTH OF #136120 : FISH-EYE DISEASE; FED *136130 : FLAVIN-CONTAINING MONOOXYGENASE 1; FMO1 *136131 : FLAVIN-CONTAINING MONOOXYGENASE 4; FMO4 *136132 : FLAVIN-CONTAINING MONOOXYGENASE 3; FMO3 136140 : FLOATING-HARBOR SYNDROME 136150 : FLOOD FACTOR DEFICIENCY 136200 : FLUSHING OF EARS AND SOMNOLENCE *136300 : FLYNN-AIRD SYNDROME *136350 : FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1 *136351 : FMS-RELATED TYROSINE KINASE 3; FLT3 *136352 : FMS-LIKE TYROSINE KINASE 4; FLT4 136400 : FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA *136425 : FOLATE RECEPTOR 2, FETAL; FOLR2 *136430 : FOLATE RECEPTOR 1, ADULT; FOLR1 *136435 : FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR *136440 : FOLLICULAR-VARIANT-TRANSLOCATION GENE; FVT1 *136470 : FOLLISTATIN; FST 136480 : FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL *136490 : FORMALDEHYDE DEHYDROGENASE; FDH *136500 : FOCAL FACIAL DERMAL DYSPLASIA *136510 : FOLYLPOLYGLUTAMATE SYNTHETASE; FPGS *136515 : FOS-LIKE ANTIGEN 1; FOSL1 #136520 : FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME *136530 : FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB *136533 : FORKHEAD BOX O1A; FOXO1A *136535 : FORMIN; FMN *136537 : FORMYL PEPTIDE RECEPTOR 1; FPR1 *136538 : FORMYL PEPTIDE RECEPTOR-LIKE 1; FPRL1 *136539 : FORMYL PEPTIDE RECEPTOR-LIKE 2; FPRL2 #136540 : FRAGILE SITE 10q23 *136550 : MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1 #136560 : FRAGILE SITE 11q13 #136570 : FRAGILE SITE 16p12 #136580 : FRAGILE SITE 16q22; FRA16A #136590 : FRAGILE SITE 20p11 136600 : FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS #136610 : FRAGILE SITE 2q11 #136620 : FRAGILE SITE 10q25 #136630 : FRAGILE SITE, FOLIC ACID TYPE, RARE, fra(12)(q13.1); FRA12A #136640 : FRAGILE SITE 9q32 ^136650 : MOVED TO 601153 #136660 : FRAGILE SITE 17p12 #136670 : FRAGILE SITE: ADDITIONAL TYPES #136680 : FRASIER SYNDROME 136750 : FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 1, MOUSE, HOMOLOG OF; FIM1 136760 : FRONTONASAL DYSPLASIA 136770 : FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 3, MOUSE, HOMOLOG OF; FIM3 #136800 : CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL *136820 : FUCOSIDASE, ALPHA-L, 2; FUCA2 136830 : FUCOSIDASE REGULATOR *136835 : FUCOSYLTRANSFERASE 5; FUT5 *136836 : FUCOSYLTRANSFERASE 6; FUT6 *136840 : FULL-LENGTH RETROVIRAL SEQUENCE 1; FRV1 *136850 : FUMARATE HYDRATASE; FH *136870 : FULL-LENGTH RETROVIRAL SEQUENCE 2; FRV2 #136880 : FUNDUS ALBIPUNCTATUS *136890 : FULL-LENGTH RETROVIRAL SEQUENCE 3; FRV3 #136900 : FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD *136950 : PAIRED BASIC AMINO ACID CLEAVING ENZYME; PACE 137000 : FUTCHER LINE *137010 : F9 EMBRYONIC ANTIGEN; FEA *137020 : TISSUE-SPECIFIC TRANSPLANTATION ANTIGEN 3; TSTA3 *137025 : FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN *137026 : G PROTEIN-COUPLED RECEPTOR KINASE 2 (DROSOPHILA)-LIKE; GPRK2L *137028 : GALACTOKINASE 2; GALK2 137030 : GALACTOSE + ACTIVATOR; GLAT ^137033 : MOVED TO 153619 *137035 : GALANIN; GAL 137040 : GALLBLADDER, AGENESIS OF 137050 : GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF *137060 : UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 1; B4GALT1 *137061 : GALACTOSYLTRANSFERASE ACTIVATOR; GTA *137070 : FUSION, DERIVED FROM 12-16 TRANSLOCATION, MALIGNANT LIPOSARCOMA; FUS *137100 : IMMUNOGLOBULIN A DEFICIENCY SUSCEPTIBILITY 1; IGAD1 137130 : GASTRIC SNEEZING *137140 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2 *137141 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4 *137142 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5; GABRA5 *137143 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6; GABRA6 *137150 : 4-@AMINOBUTYRATE AMINOTRANSFERASE; ABAT *137160 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1 *137161 : GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT RHO1 *137162 : GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT RHO2 *137163 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD *137164 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2 *137165 : SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1 *137166 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1; GABRG1 *137167 : GAMMA-GLUTAMYL CARBOXYLASE; GGCX *137168 : GAMMA-GLUTAMYLTRANSFERASE-LIKE ACTIVITY1; GGTLA1 *137170 : GAMMA-GLUTAMYLCYCLOTRANSFERASE; GCTG *137181 : GAMMA-GLUTAMYLTRANSFERASE 2; GGT2 *137190 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1 *137192 : GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3 137200 : GAMSTORP-WOHLFART SYNDROME *137207 : GLYCOPROTEIN A REPETITIONS PREDOMINANT; GARP 137210 : GASTRIC VOLVULUS, INTRATHORACIC #137215 : GASTRIC CANCER *137216 : ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT; ATP4A *137217 : ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE; ATP4B 137220 : GASTRIC JUICE PEPTIDES *137240 : GASTRIC INHIBITORY POLYPEPTIDE; GIP *137241 : GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR 137245 : GASTRIC LYMPHOMA, PRIMARY *137250 : GASTRIN; GAS *137260 : GASTRIN-RELEASING POLYPEPTIDE; GRP 137270 : GASTROCUTANEOUS SYNDROME 137280 : GASTRITIS, FAMILIAL GIANT HYPERTROPHIC *137290 : TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TACSTD2 *137295 : GATA-BINDING PROTEIN 2; GATA2 *137350 : GELSOLIN; GSN #137357 : GENITOURINARY DYSPLASIA COMPONENT OF WAGR SYNDROME; GUD 137360 : GENOCHONDROMATOSIS 137370 : GENU VALGUM, ST. HELENA FAMILIAL 137400 : GEOGRAPHIC TONGUE AND FISSURED TONGUE #137440 : GERSTMANN-STRAUSSLER DISEASE; GSD *137500 : GIANT NEUTROPHIL LEUKOCYTES 137550 : GIANT PIGMENTED HAIRY NEVUS; GPHN 137560 : GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA *137570 : SOLUTE CARRIER FAMILY 20, MEMBER 1; SLC20A1 137575 : GIGANTIFORM CEMENTOMA, FAMILIAL *137580 : GILLES DE LA TOURETTE SYNDROME; GTS #137600 : IRIDOGONIODYSGENESIS, TYPE 2; IRID2 137700 : GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE #137750 : GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET; JOAG #137760 : GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG 137763 : GLAUCOMA AND SLEEP APNEA 137765 : GLAUCOMA-LENS ECTOPIA-MICROSPHEROPHAKIA-STIFFNESS-SHORTNESS SYNDROME; GEMSS *137780 : GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP *137800 : GLIOMA OF BRAIN 137900 : GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN #137920 : GLOMERULOCYSTIC KIDNEY DISEASE, HYPOPLASTIC TYPE; GCKD 137940 : GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES 137950 : GLOMERULOPATHY WITH GIANT FIBRILLAR DEPOSITS *137960 : GLOMERULOSCLEROSIS GENE Mpv17, HUMAN HOMOLOG OF #138000 : GLOMUVENOUS MALFORMATIONS; GVM *138030 : GLUCAGON; GCG *138032 : GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; GLP1R *138033 : GLUCAGON RECEPTOR; GCGR ^138035 : MOVED TO 230800 *138040 : GLUCOCORTICOID RECEPTOR; GCCR 138060 : GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1 138070 : GLUCOGLYCINURIA *138079 : GLUCOKINASE; GCK *138090 : GLUCOSE DEHYDROGENASE; GDH *138100 : HEXOSE-6-PHOSPHATE DEHYDROGENASE; H6PD 138110 : GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL *138120 : HEAT-SHOCK 70-KD PROTEIN 5; HSPA5 *138130 : GLUTAMATE DEHYDROGENASE 1; GLUD1 *138140 : SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1 *138150 : GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL; GOT2 *138160 : SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2; SLC2A2 *138170 : SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3; SLC2A3 *138180 : GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE; GOT1 *138190 : SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; SLC2A4 *138200 : GLUTAMIC-PYRUVATE TRANSAMINASE; GPT 138210 : GLUTAMATE-PYRUVATE TRANSAMINASE, MITOCHONDRIAL; GPT2 ^138220 : MOVED TO 138200 *138230 : SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5; SLC2A5 ^138240 : MOVED TO 138170 *138243 : GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3 *138244 : GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2 *138245 : GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1 *138246 : GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4 *138247 : GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2 *138248 : GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1 *138249 : GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1 *138250 : 1-@PYRROLINE-5-CARBOXYLATE SYNTHETASE; PYCS *138251 : GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN; GRINA *138252 : GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B *138253 : GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A *138254 : GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C *138270 : GLUTATHIONE S-TRANSFERASE, MU-1-LIKE; GSTM1L *138275 : GLUTAMIC ACID DECARBOXYLASE 2; GAD2 *138276 : GLUTAMIC ACID DECARBOXYLASE 3; GAD3 138277 : GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM *138280 : GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS *138290 : GLUTAMATE-AMMONIA LIGASE; GLUL *138292 : GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1 *138295 : GLUTAMYL-PROLYL-tRNA SYNTHETASE; EPRS *138297 : GLUTAMYL AMINOPEPTIDASE; ENPEP *138300 : GLUTATHIONE REDUCTASE; GSR *138319 : GLUTATHIONE PEROXIDASE 2; GPX2 *138320 : GLUTATHIONE PEROXIDASE; GPX1 *138321 : GLUTATHIONE PEROXIDASE 3; GPX3 *138322 : GLUTATHIONE PEROXIDASE 4; GPX4 *138330 : GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1; MGST1 *138333 : GLUTATHIONE S-TRANSFERASE, MU-4; GSTM4 ^138335 : MOVED TO 138370 138340 : GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE *138350 : GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1 *138359 : GLUTATHIONE S-TRANSFERASE, ALPHA-1; GSTA1 *138360 : GLUTATHIONE S-TRANSFERASE, ALPHA-2; GSTA2 ^138370 : MOVED TO 134660 *138380 : GLUTATHIONE S-TRANSFERASE, MU-2; GSTM2 *138385 : GLUTATHIONE S-TRANSFERASE, MU-5; GSTM5 *138390 : GLUTATHIONE S-TRANSFERASE, MU-3; GSTM3 138391 : GLUTATHIONE S-TRANSFERASE 6 *138400 : GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPD *138420 : GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1; GPD1 *138430 : GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2 *138440 : PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE; GART *138450 : SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL; SHMT2 *138470 : PROPERDIN FACTOR B; BF *138480 : GLYCINE AUXOTROPH B, HUMAN COMPLEMENT FOR HAMSTER; GLY B+; GLYB *138491 : GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1 *138492 : GLYCINE RECEPTOR, BETA SUBUNIT; GLRB 138500 : GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS *138550 : GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB *138570 : GLYCOGEN SYNTHASE 1; GYS1 *138571 : GLYCOGEN SYNTHASE 2; GYS2 *138590 : GLYCOPHORIN E; GYPE *138600 : OROSOMUCOID 1; ORM1 *138610 : OROSOMUCOID 2; ORM2 *138670 : ALPHA-1-B-GLYCOPROTEIN; A1BG *138680 : ALPHA-2-HS-GLYCOPROTEIN; AHSG *138700 : APOLIPOPROTEIN H; APOH 138710 : GLYCOPROTEIN, RENAL *138720 : GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB *138750 : GLYOXALASE I; GLO1 *138760 : HYDROXYACYL GLUTATHIONE HYDROLASE; HAGH 138770 : GMS SYNDROME 138790 : GOITER, MULTINODULAR, CYSTIC RENAL DISEASE AND DIGITAL ANOMALIES *138800 : GOITER, MULTINODULAR 1; MNG1 *138850 : GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR *138890 : GOOSECOID; GSC 138900 : GOUT 138920 : GRANDDAD SYNDROME 138930 : GRANT SYNDROME *138945 : GRANULIN; GRN *138960 : COLONY-STIMULATING FACTOR 2; CSF2 *138965 : SMALL INDUCIBLE CYTOKINE SUBFAMILY B, MEMBER 6; SCYB6 *138970 : COLONY-STIMULATING FACTOR 3; CSF3 *138971 : COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE; CSF3R 138972 : CCAAT/ENHANCER-BINDING PROTEIN, GAMMA; CEBPG *138981 : GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA; CSF2RB 138990 : GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL DOMINANT TYPE 139000 : GRANULOSIS RUBRA NASI *139080 : SOLUTE CARRIER FAMILY 25, MEMBER 16; SLC25A16 *139090 : GRAY PLATELET SYNDROME; GPS *139100 : GRAYING OF HAIR, PRECOCIOUS *139110 : GRO2 ONCOGENE; GRO2 *139111 : GRO3 ONCOGENE; GRO3 *139130 : GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3; GNB3 *139139 : NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1 ^139145 : MOVED TO 139139 *139150 : RAS p21 PROTEIN ACTIVATOR 1; RASA1 *139160 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ *139180 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE-h; GNAIH *139185 : GROWTH ARREST-SPECIFIC 1; GAS1 *139190 : GROWTH HORMONE-RELEASING HORMONE; GHRH *139191 : GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR *139200 : GROUP-SPECIFIC COMPONENT; GC 139210 : GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE *139220 : GROWTH-RATE-CONTROLLING FACTOR 1; GCF1 *139230 : GROWTH-RATE-CONTROLLING FACTOR 2; GCF2 *139240 : GROWTH HORMONE 2; GH2 *139250 : GROWTH HORMONE 1; GH1 *139255 : METALLOTHIONEIN 3; MT3 *139259 : G1-TO-S PHASE TRANSITION 1; GSPT1 *139260 : GUANINE DEAMINASE; GDA *139265 : GUANINE MONOPHOSPHATE REDUCTASE *139270 : GUANYLATE KINASE 1; GUK1 139280 : GUANYLATE KINASE 2; GUK2 *139290 : GUANYLATE KINASE 3; GUK3 139300 : GYNECOMASTIA, HEREDITARY *139310 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1; GNAI1 *139311 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1 *139312 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL *139313 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11 *139314 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15 *139320 : GNAS COMPLEX LOCUS; GNAS *139330 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNAT1 *139340 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNAT2 *139350 : KERATIN 1; KRT1 *139360 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2 *139370 : GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3; GNAI3 *139380 : GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1 *139390 : GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2; GNB2 *139391 : GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING, 2 *139392 : GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A 139393 : GUILLAIN-BARRE SYNDROME, FAMILIAL *139395 : GUSTDUCIN, ALPHA POLYPEPTIDE *139396 : GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3 *139397 : GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3 139400 : HAIR WHORL 139450 : HAIR, CURLY 139500 : HAIRY EARS 139600 : HAIRY ELBOWS *139605 : 'HAIRY,' DROSOPHILA, HOMOLOG OF; HRY 139630 : HAIRY NOSE TIP *139650 : HAIRY PALMS AND SOLES 139750 : HAND AND FOOT DEFORMITY WITH FLAT FACIES 139800 : HAND CLASPING PATTERN 139900 : HANDEDNESS #140000 : HAND-FOOT-UTERUS SYNDROME *140050 : GRANZYME A; GZMA ^140090 : MOVED TO 189903 *140100 : HAPTOGLOBIN; HP *140210 : HAPTOGLOBIN-RELATED PROTEIN GENE; HPR *140300 : HASHIMOTO STRUMA #140340 : HAW RIVER SYNDROME *140350 : HAWKINSINURIA 140400 : PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II 140450 : HEART-HAND SYNDROME, SPANISH TYPE 140500 : HEART, MALFORMATION OF *140550 : HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A *140555 : HEAT-SHOCK 70-KD PROTEIN 6; HSPA6 *140556 : HEAT-SHOCK 70-KD PROTEIN 7; HSPA7 *140559 : HEAT-SHOCK 70-KD PROTEIN-LIKE 1; HSPA1L *140560 : HEAT-SHOCK 70-KD PROTEIN 2; HSPA2 *140570 : HEAT-SHOCK 70-KD PROTEIN 3; HSPA3 *140571 : HEAT-SHOCK 90-KD PROTEIN 1, ALPHA; HSPCA *140572 : HEAT-SHOCK 90-KD PROTEIN 1, BETA; HSPCB *140573 : HEAT-SHOCK 90-KD PROTEIN 1, ALPHA-LIKE 1; HSPCAL1 *140574 : HEAT-SHOCK 90-KD PROTEIN 1, ALPHA-LIKE 2; HSPCAL2 *140575 : HEAT-SHOCK 90-KD PROTEIN 1, ALPHA-LIKE 3; HSPCAL3 *140576 : HEAT-SHOCK 90-KD PROTEIN 1, ALPHA-LIKE 4; HSPCAL4 *140580 : HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1 *140581 : HEAT-SHOCK TRANSCRIPTION FACTOR 2; HSF2 140600 : OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS #140700 : HEINZ BODY ANEMIAS *140750 : SUPPRESSOR OF TUMORIGENICITY 5; ST5 140850 : HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE 140900 : HEMANGIOMAS OF SMALL INTESTINE 141000 : HEMANGIOMA-THROMBOCYTOPENIA SYNDROME *141180 : HEMATOPOIETIC PROTEIN HEM-1; HEM1 #141200 : HEMATURIA, BENIGN FAMILIAL; BFH *141250 : HEME OXYGENASE 1; HMOX1 *141251 : HEME OXYGENASE 2; HMOX2 141300 : HEMIFACIAL ATROPHY, PROGRESSIVE; HFA *141350 : HEMIFACIAL HYPERPLASIA WITH STRABISMUS; HFH 141400 : HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS 141405 : HEMIFACIAL SPASM, FAMILIAL #141500 : MIGRAINE, FAMILIAL HEMIPLEGIC, 1; MHP1 141700 : HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES #141749 : HEMOGLOBIN F, HEREDITARY PERSISTENCE OF, PANCELLULAR #141750 : HEMOGLOBIN H-RELATED MENTAL RETARDATION *141800 : HEMOGLOBIN--ALPHA LOCUS 1; HBA1 *141850 : HEMOGLOBIN--ALPHA LOCUS 2; HBA2 *141860 : HEMOGLOBIN--ALPHA LOCUS 3 *141900 : HEMOGLOBIN--BETA LOCUS; HBB ^141940 : MOVED TO 141900 *142000 : HEMOGLOBIN--DELTA LOCUS; HBD *142100 : HEMOGLOBIN--EPSILON LOCUS; HBE1 *142200 : HEMOGLOBIN, GAMMA A; HBG1 *142210 : H1 HISTONE FAMILY, MEMBER 3; H1F3 *142220 : H1 HISTONE FAMILY, MEMBER 4; H1F4 *142230 : HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34 *142240 : HEMOGLOBIN--THETA-1 LOCUS; HBQ1 *142250 : HEMOGLOBIN, GAMMA G; HBG2 ^142270 : MOVED TO 142200 *142290 : HEMOPEXIN; HPX ^142300 : MOVED TO 142310 #142309 : HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN *142310 : HEMOGLOBIN--ZETA LOCUS; HBZ 142330 : HEPATIC ADENOMAS, FAMILIAL ^142333 : MOVED TO 114550 *142335 : HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, HETEROCELLULAR, INDIAN TYPE; HPFH2 142340 : HERNIA, DIAPHRAGMATIC 142350 : HERNIA, DOUBLE INGUINAL *142360 : HEPARIN COFACTOR II; HCF2 *142370 : HEMOPOIETIC CELL KINASE; HCK ^142380 : MOVED TO 114550 *142385 : HEPATIC LEUKEMIA FACTOR; HLF *142390 : HEPATIC PROTEIN; HEP10 142395 : HEPATITIS B VACCINE, RESPONSE TO *142400 : HERNIA, HIATUS *142408 : MACROPHAGE STIMULATING 1; MST1 *142409 : HEPATOCYTE GROWTH FACTOR; HGF *142410 : TRANSCRIPTION FACTOR 1; TCF1 ^142420 : REMOVED FROM DATABASE *142440 : HEPSIN; HPN *142445 : NEUREGULIN 1; NRG1 *142450 : HERPESVIRUS SENSITIVITY; HV1S *142460 : SYNDECAN 2; SDC2 *142461 : HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2 *142470 : HETEROCELLULAR HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN 142500 : HETEROCHROMIA IRIDIS ^142510 : MOVED TO 300049 142550 : HEXOKINASE OF SPERMATOZOA *142560 : HLA-B-ASSOCIATED TRANSCRIPT 1; BAT1 *142570 : HEXOKINASE 3; HK3 *142580 : HLA-B-ASSOCIATED TRANSCRIPT 2; BAT2 *142590 : HLA-B-ASSOCIATED TRANSCRIPT 3; BAT3 *142600 : HEXOKINASE 1; HK1 *142610 : HLA-B-ASSOCIATED TRANSCRIPT 4; BAT4 *142620 : HLA-B-ASSOCIATED TRANSCRIPT 5; BAT5 *142622 : HIPPOCALCIN; HPCA #142623 : HIRSCHSPRUNG DISEASE 142625 : HIRSUTISM--SKELETAL DYSPLASIA--MENTAL RETARDATION SYNDROME 142630 : HISTIOCYTOSIS, PROGRESSIVE MUCINOUS *142640 : HISTIDINE-RICH GLYCOPROTEIN; HRG *142660 : HEXOSAMINIDASE C; HEXC *142669 : HIP DYSPLASIA, BEUKES TYPE #142680 : PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT 142690 : HIDRADENITIS SUPPURATIVA, FAMILIAL *142695 : HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP 142700 : HIP, DISLOCATION OF, CONGENITAL *142701 : HISTATIN 1; HTN1 *142702 : HISTATIN 3; HTN3 *142703 : HISTAMINE RECEPTOR H2; HRH2 *142704 : HISTIDINE DECARBOXYLASE; HDC *142705 : HISTIDINE-RICH CALCIUM-BINDING PROTEIN; HRC *142708 : H1 HISTONE FAMILY, MEMBER 0; H1F0 *142709 : H1 HISTONE FAMILY, MEMBER 1; H1F1 *142710 : H1 HISTONE FAMILY, MEMBER 2; H1F2 *142711 : H1 HISTONE FAMILY, MEMBER 5; H1F5 *142712 : H1 HISTONE FAMILY, MEMBER T; H1FT *142720 : HISTONE 2A FAMILY, MEMBER O; H2AFO 142730 : HISTIOCYTIC DERMATOARTHRITIS *142750 : H4 HISTONE, FAMILY 2; H4F2 ^142760 : MOVED TO 142720 *142763 : H2AZ HISTONE; H2AZ *142765 : REGULATORY FACTOR X, 2; RFX2 142770 : HLA MODIFIER *142780 : H3 HISTONE, FAMILY 2; H3F2 *142790 : CD74 ANTIGEN; CD74 *142795 : HLA-8 HISTOCOMPATIBILITY TYPE; HLA8 *142800 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A *142810 : HISTIDYL-tRNA SYNTHETASE; HARS *142830 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B *142840 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C; HLA-C *142850 : HLA-D HISTOCOMPATIBILITY TYPE *142855 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA; HLA-DMA *142856 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA; HLA-DMB *142857 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1 *142858 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1 *142860 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA ^142870 : REMOVED FROM DATABASE *142871 : HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G *142880 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1 *142890 : HLA-MT HISTOCOMPATIBILITY TYPE; HLA-MT #142900 : HOLT-ORAM SYNDROME; HOS *142910 : 3-@HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR *142920 : HLA-DO HISTOCOMPATIBILITY TYPE; HLA-DO ^142925 : MOVED TO 142800 *142930 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA; HLA-DNA *142940 : 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1, SOLUBLE; HMGCS1 #142945 : HOLOPROSENCEPHALY 3; HPE3 #142946 : HOLOPROSENCEPHALY 4; HPE4 *142950 : HOMEO BOX A7; HOXA7 *142951 : HOMEO BOX A6; HOXA6 *142952 : HOMEO BOX A5; HOXA5 *142953 : HOMEO BOX A4; HOXA4 *142954 : HOMEO BOX A3; HOXA3 *142955 : HOMEO BOX A1; HOXA1 *142956 : HOMEO BOX A9; HOXA9 *142957 : HOMEO BOX A10; HOXA10 *142958 : HOMEO BOX A11; HOXA11 *142959 : HOMEO BOX A13; HOXA13 *142960 : HOMEO BOX B5; HOXB5 *142961 : HOMEO BOX B6; HOXB6 *142962 : HOMEO BOX B7; HOXB7 *142963 : HOMEO BOX B8; HOXB8 *142964 : HOMEO BOX B9; HOXB9 *142965 : HOMEO BOX B4; HOXB4 *142966 : HOMEO BOX B3; HOXB3 *142967 : HOMEO BOX B2; HOXB2 *142968 : HOMEO BOX B1; HOXB1 *142970 : HOMEO BOX C8; HOXC8 *142971 : HOMEO BOX C9; HOXC9 *142972 : HOMEO BOX C6; HOXC6 *142973 : HOMEO BOX 3D; HOX3D *142974 : HOMEO BOX C4; HOXC4 *142975 : HOMEO BOX 3F; HOX3F *142976 : HOMEO BOX C13; HOXC13 *142980 : HOMEO BOX D3; HOXD3 *142981 : HOMEO BOX D4; HOXD4 *142982 : HOMEO BOX D9; HOXD9 *142983 : MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 1; MSX1 *142984 : HOMEO BOX D10; HOXD10 *142985 : HOMEO BOX D8; HOXD8 *142986 : HOMEO BOX D11; HOXD11 *142987 : HOMEO BOX D1; HOXD1 *142988 : HOMEO BOX D12; HOXD12 *142989 : HOMEO BOX D13; HOXD13 ^142990 : MOVED TO 142981 *142991 : EVEN-SKIPPED HOMEO BOX 2; EVX2 *142992 : HOMEO BOX (H6 FAMILY) 1; HMX1 *142993 : CEH10 HOMEODOMAIN-CONTAINING HOMOLOG; CHX10 *142994 : HOMEO BOX GENE HB9; HLXB9 *142995 : HOMEO BOX GENE HB24 *142996 : EVEN-SKIPPED HOMEO BOX 1; EVX1 *143000 : HORNER SYNDROME *143010 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E; HLA-E #143020 : HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED; HPA1 *143023 : CHROMOSOME 11 OPEN READING FRAME 13; C11ORF13 *143024 : GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1; GNL1 *143025 : HTLV-RELATED ENDOGENOUS SEQUENCE 1; HRES1 *143030 : CD9 ANTIGEN; CD9 *143040 : ANTIGEN DEFINED BY MONOCLONAL ANTIBODY F10.44.2 143050 : HUMERORADIAL SYNOSTOSIS *143054 : HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2 *143055 : HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 EXPRESSION 1; HIVE1 *143060 : HUMAN LEUKOCYTE ANTIGEN MIC6; MIC6 ^143065 : MOVED TO 107271 ^143070 : REMOVED FROM DATABASE ^143080 : REMOVED FROM DATABASE *143089 : HUMAN T-CELL LEUKEMIA VIRUS ENHANCER FACTOR; HTLF *143090 : HUMAN T-CELL LEUKEMIA VIRUS RECEPTOR; HTLVR 143095 : HUMEROSPINAL DYSOSTOSIS *143100 : HUNTINGTON DISEASE; HD *143110 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F; HLA-F 143150 : H-Y ANTIGEN RECEPTOR *143170 : MALE-ENHANCED ANTIGEN; MEA *143200 : HYALOIDEORETINAL DEGENERATION OF WAGNER *143400 : MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MRD *143450 : HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB 143460 : 5-@HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR 143465 : ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD 143470 : HYPERALPHALIPOPROTEINEMIA #143500 : GILBERT SYNDROME *143850 : ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE 143860 : HYPERCHLORHIDROSIS, ISOLATED *143870 : HYPERCALCIURIA, ABSORPTIVE, 1 143880 : HYPERCALCEMIA, IDIOPATHIC, OF INFANCY #143890 : HYPERCHOLESTEROLEMIA, FAMILIAL #144010 : HYPERCHOLESTEROLEMIA, FAMILIAL, TYPE B 144020 : HYPERCHOLESTEROLEMIA SUPPRESSOR 144050 : HYPERHEPARINEMIA 144100 : HYPERHIDROSIS, GUSTATORY 144110 : HYPERHIDROSIS PALMARIS ET PLANTARIS 144120 : HYPERIMMUNOGLOBULIN G1(A1) SYNDROME *144150 : HYPERKERATOSIS LENTICULARIS PERSTANS; HLP 144190 : HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME *144200 : HYPERKERATOSIS, LOCALIZED EPIDERMOLYTIC #144250 : HYPERLIPIDEMIA, FAMILIAL COMBINED 144300 : HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS #144400 : HYPERLIPOPROTEINEMIA, TYPE II 144600 : HYPERLIPOPROTEINEMIA, TYPE IV 144650 : HYPERLIPOPROTEINEMIA, TYPE V #144700 : RENAL CELL CARCINOMA 1; RCC1 *144750 : HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS 144755 : HYPEROSTOSIS CRANIALIS INTERNA 144800 : HYPEROSTOSIS FRONTALIS INTERNA #145000 : HYPERPARATHYROIDISM 1; HRPT1 *145001 : HYPERPARATHYROIDISM 2; HRPT2 *145100 : HYPERPIGMENTATION OF EYELIDS 145200 : HYPERPIGMENTATION OF FULDAUER AND KUIJPERS *145250 : HYPERPIGMENTATION, FAMILIAL PROGRESSIVE #145260 : PSEUDOHYPOALDOSTERONISM, TYPE II; PHA2 145270 : HYPERPROGLUCAGONEMIA 145290 : HYPERREFLEXIA; HRX 145295 : HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL 145300 : HYPERSENSITIVITY PNEUMONITIS, FAMILIAL 145350 : HYPERTAURINURIC CARDIOMYOPATHY *145400 : HYPERTELORISM *145410 : HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS *145420 : HYPERTELORISM, TEEBI TYPE #145500 : HYPERTENSION, ESSENTIAL *145505 : HYPERTENSION-ASSOCIATED SA, RAT, HOMOLOG OF; SAH 145590 : HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA #145600 : MALIGNANT HYPERTHERMIA SUSCEPTIBILITY 1; MHS1 #145650 : HYPERTHYROIDISM, FAMILIAL, DUE TO INAPPROPRIATE THYROTROPIN SECRETION *145680 : HYPERTHYROXINEMIA, FAMILIAL *145700 : HYPERTRICHOSIS UNIVERSALIS *145701 : HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1 *145750 : HYPERTRIGLYCERIDEMIA, FAMILIAL *145800 : HYPERTROPHIA MUSCULORUM VERA #145900 : HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS #145980 : HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1 *145981 : HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2 #146000 : HYPOCHONDROPLASIA; HCH #146110 : HYPOGONADOTROPIC HYPOGONADISM ^146150 : MOVED TO 300337 146160 : HYPOMELIA WITH MULLERIAN DUCT ANOMALIES #146200 : HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH #146255 : HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA #146300 : HYPOPHOSPHATASIA, ADULT TYPE 146350 : HYPOPHOSPHATEMIC BONE DISEASE; HBD 146390 : HYPOPITUITARISM ASSOCIATED WITH 18p- SYNDROME 146400 : HYPOPLASIA OF TEETH ROOTS 146450 : HYPOSPADIAS 146500 : HYPOTENSION, ORTHOSTATIC #146510 : PALLISTER-HALL SYNDROME; PHS *146520 : HYPOTRICHOSIS SIMPLEX OF SCALP *146530 : HYPOTRICHOSIS WITH LIGHT-COLORED HAIR AND FACIAL MILIA *146550 : HYPOTRICHOSIS, MARIE UNNA TYPE 146580 : HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE SUPPRESSOR *146590 : ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM 146600 : ICHTHYOSIS HYSTRIX GRAVIOR *146630 : INTERCELLULAR ADHESION MOLECULE 2; ICAM2 *146631 : INTERCELLULAR ADHESION MOLECULE 3; ICAM3 *146640 : INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2; ITIH2 *146650 : INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3; ITIH3 *146660 : INTERLEUKIN 7; IL7 *146661 : INTERLEUKIN 7 RECEPTOR; IL7R *146680 : INSULIN-DEGRADING ENZYME; IDE *146690 : IMP DEHYDROGENASE 1; IMPDH1 *146691 : IMP DEHYDROGENASE 2; IMPDH2 ^146692 : MOVED TO 146690 *146700 : ICHTHYOSIS VULGARIS *146710 : INTERLEUKIN 2 RECEPTOR, BETA; IL2RB 146720 : ICHTHYOSIS--CHEEK--EYEBROW SYNDROME *146730 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGFBP1 *146731 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IGFBP2 *146732 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3 *146733 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4; IGFBP4 *146734 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IGFBP5 *146735 : INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6 *146738 : INSULIN-LIKE 3; INSL3 *146740 : Fc FRAGMENT OF IgG, LOW AFFINITY IIIa, RECEPTOR FOR; FCGR3A 146750 : ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT FORM *146760 : Fc FRAGMENT OF IgG, HIGH AFFINITY Ia, RECEPTOR FOR; FCGR1A *146770 : IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1; IGLL1 ^146771 : MOVED TO 146770 *146780 : IMMUNOGLOBULIN KAPPA DELETING ELEMENT; IGKDEL *146790 : Fc FRAGMENT OF IgG, LOW AFFINITY IIa, RECEPTOR FOR; FCGR2A #146800 : ICHTHYOSIS, BULLOUS TYPE *146810 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL; IPHEG *146820 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT 146830 : IMMUNE DEFICIENCY, FAMILIAL VARIABLE 146840 : IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST 146850 : IMMUNE SUPPRESSION; IS *146880 : MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1 *146900 : IgA CONSTANT HEAVY CHAIN 1; IGHA1 *146910 : IMMUNOGLOBULIN: D (DIVERSITY) REGION OF HEAVY CHAIN *146920 : INTERFERON-INDUCED PROTEIN 4; IFI4 *146928 : INTERLEUKIN 8 RECEPTOR, BETA; IL8RB *146929 : INTERLEUKIN 8 RECEPTOR, ALPHA; IL8RA *146930 : INTERLEUKIN 8; IL8 *146931 : INTERLEUKIN 9; IL9 ^146932 : MOVED TO 300007 *146933 : INTERLEUKIN 10 RECEPTOR, ALPHA; IL10RA ^146940 : MOVED TO 147220 *146950 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL; IHG *146960 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRTGAL; ITG *146970 : IMMUNOGLOBULIN: J REGION GENES OF KAPPA LIGHT CHAIN; IGKJ *146980 : IMMUNOGLOBULIN: VARIABLE REGION GENES OF KAPPA LIGHT CHAIN; IGKV 146990 : IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2 *147000 : IgA CONSTANT HEAVY CHAIN 2; IGHA2 *147010 : IMMUNOGLOBULIN: J (JOINING) LOCI OF HEAVY CHAIN; IGHJ *147020 : IMMUNOGLOBULIN MU; IGHM *147040 : INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; IFIT2 *147045 : Fc FRAGMENT OF IgA, RECEPTOR FOR; FCAR *147050 : IgE RESPONSIVENESS, ATOPIC; IGER *147060 : HYPER-IgE SYNDROME *147061 : IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES *147070 : IMMUNOGLOBULIN HEAVY VARIABLE CLUSTER; IGHV *147080 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1 *147090 : IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2 *147100 : IgG HEAVY CHAIN LOCUS; IGHG1 *147110 : IMMUNOGLOBULIN Gm2; IGHG2 *147120 : IMMUNOGLOBULIN Gm3; IGHG3 *147130 : IMMUNOGLOBULIN Gm4; IGHG4 *147138 : MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2; MS4A2 *147139 : Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT; FCER1G *147140 : Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT; FCER1A *147141 : TRANSCRIPTION FACTOR 3; TCF3 *147150 : MYXOVIRUS RESISTANCE 1, MOUSE, HOMOLOG OF; MX1 ^147160 : MOVED TO 147180 *147170 : IMMUNOGLOBULIN: HEAVY DELTA CHAIN; IGHD *147180 : IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE *147183 : RECOMBINATION SIGNAL-BINDING PROTEIN SUPPRESSOR OF HAIRLESS, DROSOPHILA, HOMOLOG OF; RBPSUH *147185 : IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108 *147200 : IMMUNOGLOBULIN KAPPA CONSTANT REGION; IGKC ^147210 : MOVED TO 147180 *147220 : IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1 *147230 : IMMUNOGLOBULIN: LAMBDA LIGHT CHAIN, J REGION GENES; IGLJ *147240 : IMMUNOGLOBULIN: LAMBDA LIGHT CHAIN, VARIABLE REGION GENES; IGLV *147245 : CD79B ANTIGEN; CD79B #147250 : SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI 147251 : INCISORS, FUSED MANDIBULAR 147260 : IMMUNOGLOBULIN SWITCH SEQUENCES *147263 : INOSITOL POLYPHOSPHATE-1-PHOSPHATASE; INPP1 *147264 : INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B *147265 : INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1 *147267 : INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3 *147270 : INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1; ITIH1 *147280 : INSULIN-LIKE GROWTH FACTOR II RECEPTOR; IGF2R *147290 : INHIBIN, BETA A; INHBA 147300 : INCISORS, LONG UPPER CENTRAL *147310 : SMALL INDUCIBLE CYTOKINE SUBFAMILY B, MEMBER 10; SCYB10 147320 : INSULIN RECEPTORS, FAMILIAL INCREASE IN 147330 : INCISORS, LOWER CENTRAL, ABSENCE OF 147350 : INCISORS, ROTATION OF UPPER CENTRAL *147360 : INVOLUCRIN; IVL *147370 : INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R *147380 : INHIBIN, ALPHA; INHA *147390 : INHIBIN, BETA B; INHBB 147400 : INCISORS, SHOVEL-SHAPED ^147410 : REMOVED FROM DATABASE *147420 : INCLUSION BODY MYOPATHY 147421 : INCLUSION BODY MYOSITIS 147430 : INDIFFERENCE TO PAIN *147435 : INDOLEAMINE 2,3-DIOXYGENASE; INDO *147440 : INSULIN-LIKE GROWTH FACTOR I; IGF1 *147450 : SUPEROXIDE DISMUTASE 1; SOD1 *147460 : SUPEROXIDE DISMUTASE 2; SOD2 *147470 : INSULIN-LIKE GROWTH FACTOR II; IGF2 #147480 : CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY; ICP *147485 : INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE; IPP *147490 : INSULIN-LIKE DNA SEQUENCE; INSL *147510 : INSULIN-RELATED DNA POLYMORPHISM; IRDN *147520 : INOSINE TRIPHOSPHATASE; ITPA *147521 : INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A; ITPKA *147522 : INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B; ITPKB 147530 : INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY 147540 : INSECT STINGS, HYPERSENSITIVITY TO *147545 : INSULIN RECEPTOR SUBSTRATE 1; IRS1 *147553 : INTERFERON, OMEGA-1; IFNW1 ^147554 : MOVED TO 147553 *147556 : INTEGRIN, ALPHA-6; ITGA6 *147557 : INTEGRIN, BETA-4; ITGB4 *147558 : INTEGRIN, BETA-6; ITGB6 *147559 : INTEGRIN, BETA-7; ITGB7 147560 : INTERFERON ANTIVIRAL DEPRESSOR *147561 : INTEGRIN, BETA-5; ITGB5 *147562 : INTERFERON, ALPHA-2; IFNA2 *147563 : INTEGRIN-BINDING SIALOPROTEIN; IBSP *147564 : INTERFERON, ALPHA-4; IFNA4 *147565 : INTERFERON, ALPHA-5; IFNA5 *147566 : INTERFERON, ALPHA-6; IFNA6 *147567 : INTERFERON, ALPHA-7; IFNA7 *147568 : INTERFERON, ALPHA-8; IFNA8 *147569 : INTERFERON, GAMMA, RECEPTOR 2; IFNGR2 *147570 : INTERFERON, GAMMA; IFNG *147571 : INTERFERON-INDUCED PROTEIN IFI-15K *147572 : INTERFERON-INDUCED PROTEIN IFI-6-16; G1P3 *147573 : INTERFERON PRODUCTION REGULATOR; IFNR *147574 : INTERFERON-STIMULATED TRANSCRIPTION FACTOR 3, GAMMA; ISGF3G *147575 : INTERFERON REGULATORY FACTOR 1; IRF1 *147576 : INTERFERON REGULATORY FACTOR 2; IRF2 *147577 : INTERFERON, ALPHA-10; IFNA10 *147578 : INTERFERON, ALPHA-13; IFNA13 *147579 : INTERFERON, ALPHA-14; IFNA14 *147580 : INTERFERON, ALPHA-16; IFNA16 ^147581 : MOVED TO 100880 *147582 : IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2; IREB2 *147583 : INTERFERON, ALPHA-17; IFNA17 *147584 : INTERFERON, ALPHA-21; IFNA21 ^147585 : MOVED TO 147660 *147586 : INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16 147590 : IRIS DYSPLASIA WITH OCULAR HYPERTELORISM, PSYCHOMOTOR RETARDATION AND SENSORINEURAL DEAFNESS 147610 : IRIS PIGMENT LAYER, CLEAVAGE OF *147620 : INTERLEUKIN 6; IL6 *147625 : ISLET CELL AUTOANTIGEN 1; ICA1 147630 : ISLET CELL ADENOMATOSIS *147640 : INTERFERON, BETA-1; IFNB1 *147650 : ISOCITRATE DEHYDROGENASE 2; IDH2 *147660 : INTERFERON, ALPHA-1; IFNA1 *147670 : INSULIN RECEPTOR; INSR *147671 : INSULIN RECEPTOR-RELATED RECEPTOR; INSRR *147678 : CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP1 *147679 : INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN *147680 : INTERLEUKIN 2; IL2 *147681 : INTERLEUKIN 11; IL11 *147683 : INTERLEUKIN 13; IL13 *147684 : INTERLEUKIN 14; IL14 *147685 : INTERLEUKIN ENHANCER-BINDING FACTOR 1; ILF1 ^147686 : MOVED TO 300119 *147690 : INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IFIT1 *147700 : ISOCITRATE DEHYDROGENASE 1; IDH1 147710 : INTUSSUSCEPTION *147720 : INTERLEUKIN 1-BETA; IL1B *147730 : INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA *147740 : INTERLEUKIN 3; IL3 *147750 : IVIC SYNDROME *147760 : INTERLEUKIN 1-ALPHA; IL1A 147770 : JOHNSON NEUROECTODERMAL SYNDROME *147780 : INTERLEUKIN 4; IL4 *147781 : INTERLEUKIN 4 RECEPTOR; IL4R *147790 : IMMUNOGLOBULIN J POLYPEPTIDE, LINKER PROTEIN FOR IMMUNOGLOBULIN ALPHA AND MU POLYPEPTIDES; IGJ #147791 : JACOBSEN SYNDROME; JBS *147795 : JANUS KINASE 1; JAK1 *147796 : JANUS KINASE 2; JAK2 *147800 : AASE-SMITH SYNDROME *147810 : INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1 *147811 : INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2 147820 : INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF *147830 : INVASION AND METASTASIS FACTORS ON CHROMOSOME 7; INM7 *147840 : INTERCELLULAR ADHESION MOLECULE 1; ICAM1 *147850 : INTERLEUKIN 5; IL5 *147851 : INTERLEUKIN 5 RECEPTOR, ALPHA; IL5RA *147860 : INTERFERON, BETA-3; IFNB3 *147870 : WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2 *147880 : INTERLEUKIN 6 RECEPTOR; IL6R *147890 : MYXOVIRUS RESISTANCE 2, MOUSE, HOMOLOG OF; MX2 *147891 : ISCHIOPATELLAR DYSPLASIA *147892 : DEIODINASE, IODOTHYRONINE, TYPE I; DIO1 *147900 : JOINT LAXITY, FAMILIAL *147910 : KALLIKREIN 1; KLK1 147920 : KABUKI SYNDROME *147935 : PROTEASE INHIBITOR 4; PI4 *147940 : ISLET AMYLOID POLYPEPTIDE; IAPP *147950 : KALLMANN SYNDROME 2; KAL2 *147960 : KALLIKREIN 2; KLK2 #148000 : KAPOSI SARCOMA *148020 : KERATIN 19; KRT19 *148021 : KERATIN, CUTICLE, ULTRAHIGH-SULFUR, 1; KRN1 *148022 : KERATIN, CUTICLE, ULTRAHIGH-SULFUR, 1-LIKE; KRN1L *148030 : KERATIN 15; KRT15 *148040 : KERATIN 5; KRT5 *148041 : KERATIN 6A; KRT6A *148042 : KERATIN 6B; KRT6B *148043 : KERATIN 3; KRT3 *148050 : KBG SYNDROME *148059 : KERATIN 7; KRT7 *148060 : KERATIN 8; KRT8 *148065 : KERATIN 13; KRT13 *148066 : KERATIN 14; KRT14 *148067 : KERATIN 16; KRT16 *148069 : KERATIN 17; KRT17 *148070 : KERATIN 18; KRT18 *148080 : KERATIN 10; KRT10 148100 : KELOIDS *148180 : FIBROBLAST GROWTH FACTOR 7; FGF7 ^148181 : MOVED TO 176943 #148190 : KERATITIS, HEREDITARY *148200 : KERATITIS FUGAX HEREDITARIA #148210 : KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT *148300 : KERATOCONUS #148350 : KERATODERMA, PALMOPLANTAR, WITH DEAFNESS 148360 : KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY *148370 : KERATOLYTIC WINTER ERYTHEMA 148390 : KERATOSES, FAMILIAL ACTINIC *148500 : TYLOSIS WITH ESOPHAGEAL CANCER; TOC 148520 : KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY *148600 : KERATOSIS PALMOPLANTARIS PAPULOSA #148700 : KERATOSIS PALMOPLANTARIS STRIATA I *148730 : KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL *148750 : KINASE-LIKE PROTEIN G7P1; G7P1 *148760 : KINESIN-LIKE 1; KNSL1 148800 : KLEEBLATTSCHAEDEL SYNDROME #148820 : KLEIN-WAARDENBURG SYNDROME 148840 : KLEINE-LEVIN HIBERNATION SYNDROME 148860 : KLIPPEL-FEIL DEFORMITY, CONDUCTIVE DEAFNESS, AND ABSENT VAGINA 148870 : KLIPPEL-FEIL DEFORMITY, DEAFNESS, AND FACIAL ASYMMETRY *148900 : KLIPPEL-FEIL SYNDROME 149000 : KLIPPEL-TRENAUNAY-WEBER SYNDROME 149100 : KNUCKLE PADS *149200 : KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS *149300 : KOILONYCHIA, HEREDITARY #149400 : KOK DISEASE 149500 : KYRLE DISEASE 149600 : LABIA MINORA, INCOMPLETE ADHESION OF 149700 : LACRIMAL DUCT DEFECT *149730 : LACRIMOAURICULODENTODIGITAL SYNDROME; LADD *149750 : LACTALBUMIN, ALPHA; LALBA *150000 : LACTATE DEHYDROGENASE-A; LDHA *150100 : LACTATE DEHYDROGENASE-B; LDHB *150150 : LACTATE DEHYDROGENASE-C; LDHC 150160 : LACTATE DEHYDROGENASE-K; LDHK 150170 : LACTIC ACIDOSIS, CHRONIC ADULT FORM *150200 : CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1 *150205 : LACTOPEROXIDASE; LPO *150210 : LACTOTRANSFERRIN; LTF 150220 : LACTOSE INTOLERANCE, CONGENITAL #150230 : LANGER-GIEDION SYNDROME; LGS *150240 : LAMININ, BETA-1; LAMB1 *150250 : LARSEN SYNDROME, AUTOSOMAL DOMINANT; LRS1 *150260 : LARYNGEAL ABDUCTOR PARALYSIS *150270 : LARYNGEAL ADDUCTOR PARALYSIS; LAP 150280 : LARYNGOMALACIA *150290 : LAMININ, GAMMA-1; LAMC1 *150292 : LAMININ, GAMMA-2; LAMC2 150300 : LARYNX, CONGENITAL PARTIAL ATRESIA OF *150310 : LAMININ, BETA-3; LAMB3 *150320 : LAMININ, ALPHA-1; LAMA1 *150325 : LAMININ, BETA-2; LAMB2 *150330 : LAMIN A/C; LMNA *150340 : LAMIN B1; LMNB1 *150341 : LAMIN B2; LMNB2 150360 : LARYNGEAL WEB, FAMILIAL *150370 : LAMININ RECEPTOR 1; LAMR1 *150390 : LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1 *150400 : LATERAL INCISORS, ABSENCE OF 150500 : LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT 150550 : LAZY LEUKOCYTE SYNDROME *150570 : LECTIN, BETA-GALACTOSIDE BINDING, SOLUBLE, 1; LGALS1 *150571 : LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2; LGALS2 150590 : LEG ULCERS, FAMILIAL, OF JUVENILE ONSET 150600 : LEGG-CALVE-PERTHES DISEASE #150699 : LEIOMYOMA, UTERINE 150700 : LEIOMYOMA OF VULVA AND ESOPHAGUS #150800 : LEIOMYOMA, HEREDITARY MULTIPLE, OF SKIN 150900 : LENTIGINES 151000 : LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC 151001 : LENTIGINOSIS, INHERITED PATTERNED *151020 : LENTIL AGGLUTININ BINDING 151050 : LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM *151100 : LEOPARD SYNDROME *151200 : LERI PLEONOSTEOSIS #151210 : THANATOPHORIC DYSPLASIA VARIANTS *151250 : LETHAL ANTIGEN--A1; AL-A1 *151290 : CD57 ANTIGEN; CD57 *151300 : LEUCYL-CYSTINYL AMINOPEPTIDASE; LNPEP *151310 : LEUCINE TRANSPORT, HIGH; LEUT *151350 : LEUCYL-tRNA SYNTHETASE; LARS 151380 : LEUKEMIA, ACUTE MONOCYTIC *151385 : RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1 *151390 : LEUKEMIA, ACUTE T-CELL; ATL #151400 : LEUKEMIA, CHRONIC LYMPHATIC; CLL *151410 : BREAKPOINT CLUSTER REGION; BCR *151430 : B-CELL CLL/LYMPHOMA 2; BCL2 *151440 : LEUKEMIA, LYMPHOID, 1; LYL1 *151441 : LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5 *151442 : STATHMIN 1; STMN1 *151443 : LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR *151445 : LEUKOCYTE ANTIGEN CD23; CD23 *151450 : LEUKOCYTE ANTIGEN GROUP FIVE; LAG5 *151460 : PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C; PTPRC ^151465 : MOVED TO 162643 151500 : LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF *151510 : INTEGRIN, ALPHA-X; ITGAX *151520 : LEUKOCYTE TYROSINE KINASE; LTK *151523 : LEUKOCYTE SURFACE ANTIGEN CD37; CD37 *151525 : LEUKOCYTE SURFACE ANTIGEN CD53; CD53 *151530 : ALANYL AMINOPEPTIDASE; ANPEP ^151540 : MOVED TO 600623 151550 : LEUKONYCHIA MACULATA *151570 : LEUKOTRIENE A4 HYDROLASE; LTA4H ^151580 : MOVED TO 142360 151590 : LICHEN SCLEROSUS ET ATROPHICUS; LSA *151600 : LEUKONYCHIA TOTALIS 151610 : LEVATOR-MEDIAL RECTUS SYNKINESIS 151620 : LICHEN PLANUS, FAMILIAL #151623 : LI-FRAUMENI SYNDROME; LFS *151625 : LIGATIN *151626 : LINE RETROTRANSPOSABLE ELEMENT 1; LRE1 *151627 : LINKIN *151628 : LINE RETROTRANSPOSABLE ELEMENT 2; LRE2 *151630 : LIP, MEDIAN NODULE OF UPPER 151640 : LIP, HAMARTOMATOUS #151660 : LIPODYSTROPHY, FAMILIAL PARTIAL; FPLD *151670 : LIPASE, HEPATIC; LIPC *151675 : LIPOCALIN 1; LCN1 151680 : LIPODYSTROPHY, PARTIAL, WITH RIEGER ANOMALY, SHORT STATURE, AND INSULINOPENIC DIABETES MELLITUS *151690 : ANNEXIN A1; ANXA1 151700 : LIPOMA OF THE CONJUNCTIVA ^151710 : MOVED TO 151740 ^151720 : MOVED TO 151740 ^151730 : MOVED TO 151740 *151740 : ANNEXIN A2; ANXA2 *151750 : LIPASE, HORMONE-SENSITIVE; LIPE 151800 : LIPOMATOSIS, FAMILIAL BENIGN CERVICAL *151900 : LIPOMATOSIS, MULTIPLE *151990 : LIPOPOLYSACCHARIDE-BINDING PROTEIN; LBP *152100 : LIPOPROTEIN TYPES--Ld SYSTEM *152200 : APOLIPOPROTEIN(a); LPA 152300 : LIPOPROTEIN TYPES--Lt SYSTEM *152310 : TISSUE FACTOR PATHWAY INHIBITOR; TFPI *152390 : ARACHIDONATE 5-LIPOXYGENASE; ALOX5 *152391 : ARACHIDONATE 12-OXIDOREDUCTASE; ALOX12 *152392 : ARACHIDONATE 15-LIPOXYGENASE; ALOX15 152400 : LIPOPROTEIN, VARIANT OF BETA 152420 : LITHIUM TRANSPORT *152422 : LOCUS CONTROL REGION, ALPHA 152423 : LIVER CELL ADHESION MOLECULE; LCAM *152424 : LOCUS CONTROL REGION, BETA *152425 : FATTY ACID CoA LIGASE, LONG-CHAIN 1; FACL1 *152426 : FATTY ACID CoA LIGASE, LONG-CHAIN 2; FACL2 *152427 : LONG QT SYNDROME 2; LQT2 #152430 : LONGEVITY *152445 : LORICRIN; LOR 152450 : LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT *152460 : LOBULAR GLOMERULOPATHY, FAMILIAL 152550 : LUMBAR STENOSIS, FAMILIAL 152600 : LUNULAE OF FINGERNAILS *152690 : THYROID AUTOANTIGEN, 70-KD; G22P1 #152700 : LUPUS ERYTHEMATOSUS, SYSTEMIC; SLE *152760 : GONADOTROPIN-RELEASING HORMONE 1; GNRH1 ^152761 : MOVED TO 138850 *152780 : LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB *152790 : LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR *152800 : LYMPHANGIECTASIA, INTESTINAL 152900 : LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY *152950 : LYMPHEDEMA, MICROCEPHALY, CHORIORETINOPATHY SYNDROME #153000 : LYMPHEDEMA AND PTOSIS #153100 : LYMPHEDEMA, HEREDITARY I *153200 : LYMPHEDEMA, HEREDITARY II *153240 : SELECTIN L; SELL *153243 : TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8; TNFRSF8 *153245 : LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1 *153280 : LYMPHOCYTE CYTOSOL POLYPEPTIDE, 40-KD *153290 : LYMPHOCYTE CYTOSOL POLYPEPTIDE, 49-KD 153300 : YELLOW NAIL SYNDROME *153310 : CHARCOT-LEYDEN CRYSTAL PROTEIN; CLC *153330 : LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LAMP1 ^153335 : MOVED TO 182284 *153337 : LYMPHOCYTE ACTIVATION GENE 3; LAG3 *153340 : LYMPHOCYTE ANTIGEN CD5; CD5 ^153360 : MOVED TO 300257 *153370 : INTEGRIN, ALPHA-L; ITGAL *153380 : LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD *153390 : LYMPHOCYTE-SPECIFIC PROTEIN-TYROSINE KINASE; LCK #153400 : LYMPHEDEMA-DISTICHIASIS SYNDROME *153420 : LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN, TYPE 3; LFA3 *153430 : LYMPHOCYTE CYTOSOLIC PROTEIN 1; LCP1 *153432 : LYMPHOCYTE-SPECIFIC PROTEIN; LSP1 *153435 : LYMPHOKINE-ACTIVATED KILLER CELL LIGAND; LAKL *153440 : LYMPHOTOXIN-ALPHA; LTA *153450 : LYSOZYME; LYZ *153454 : PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD *153455 : LYSYL OXIDASE; LOX *153456 : LYSYL OXIDASE-LIKE 1; LOXL1 153460 : MCARDLE SYNDROME, AUTOSOMAL DOMINANT 153470 : MACROCEPHALY, BENIGN FAMILIAL #153480 : MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA #153550 : 5q- SYNDROME 153600 : MACROGLOBULINEMIA, WALDENSTROM; WM *153615 : CAPPING PROTEIN, GELSOLIN-LIKE; CAPG *153618 : MACROPHAGE MANNOSE RECEPTOR; MRC1 *153619 : LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3; LGALS3 *153620 : MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF *153622 : MACROPHAGE SCAVENGER RECEPTOR; MSR1 *153630 : MACROGLOSSIA *153634 : MACROPHAGE ANTIGEN CD68; CD68 #153640 : FECHTNER SYNDROME; FTNS #153650 : EPSTEIN SYNDROME 153670 : MACROTHROMBOCYTOPENIA, BENIGN MEDITERRANEAN *153700 : MACULAR DYSTROPHY, VITELLIFORM; VMD2 #153800 : MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2 *153840 : MACULAR DYSTROPHY, ATYPICAL VITELLIFORM; VMD1 ^153860 : MOVED TO 169150 153870 : MACULAR DYSTROPHY, CONCENTRIC ANNULAR *153880 : MACULAR EDEMA, CYSTOID 153890 : MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE ^153900 : MOVED TO 600110 154000 : MACULES, HEREDITARY CONGENITAL HYPOPIGMENTED AND HYPERPIGMENTED #154020 : HYPOMAGNESEMIA 2, RENAL; HOMG2 *154030 : NUCLEASE-SENSITIVE ELEMENT-BINDING PROTEIN 1; NSEP1 *154040 : MAJOR HISTOCOMPATIBILITY COMPLEX GENE RD *154045 : LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD; LIM2 *154050 : MAJOR INTRINSIC PROTEIN OF LENS FIBER; MIP *154100 : MALATE DEHYDROGENASE, MITOCHONDRIAL; MDH2 *154200 : MALATE DEHYDROGENASE, SOLUBLE; MDH1 *154230 : SEX REVERSAL, AUTOSOMAL, 2; SRA2 *154235 : MALE GERM CELL-ASSOCIATED KINASE; MAK *154250 : MALIC ENZYME 1; ME1 *154270 : MALIC ENZYME 2; ME2 *154275 : MALIGNANT HYPERTHERMIA SUSCEPTIBILITY 2; MHS2 *154276 : MALIGNANT HYPERTHERMIA SUSCEPTIBILITY 3 *154280 : SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1; SAI1 154300 : MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH *154360 : MALTASE-GLUCOAMYLASE; MGAM *154365 : PROTEASOME 26S SUBUNIT, ATPase, 2; PSMC2 154370 : MAMMASTATIN 154400 : ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1 #154500 : TREACHER COLLINS-FRANCESCHETTI SYNDROME; TCOF *154540 : MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT; M6PR *154545 : LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2 *154550 : MANNOSEPHOSPHATE ISOMERASE; MPI *154570 : MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE *154580 : MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1; MAN2C1 *154582 : MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1 154600 : MARCUS GUNN PHENOMENON #154700 : MARFAN SYNDROME; MFS *154705 : MARFAN-LIKE CONNECTIVE TISSUE DISORDER 154750 : MARFANOID HYPERMOBILITY SYNDROME #154780 : MARSHALL SYNDROME *154790 : PROTEASE INHIBITOR 5; PI5 154800 : MAST CELL DISEASE 154850 : MASTICATORY MUSCLES, HYPERTROPHY OF *154870 : GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, MATRIX; MGP *154950 : MAX PROTEIN; MAX *155000 : MAXILLOFACIAL DYSOSTOSIS *155050 : MAXILLONASAL DYSPLASIA, BINDER TYPE #155100 : MAY-HEGGLIN ANOMALY; MHA *155120 : A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11; ADAM11 155140 : MECKEL DIVERTICULUM 155145 : CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA 155150 : MEDIAN-ULNAR NERVE COMMUNICATIONS 155200 : MEDIOSTERNAL DEPIGMENTATION LINE #155240 : MEDULLARY THYROID CARCINOMA, FAMILIAL; MTC ^155250 : MOVED TO 130130 #155255 : MEDULLOBLASTOMA *155310 : MEGADUODENUM AND/OR MEGACYSTIS *155350 : MEGALENCEPHALY 155500 : MEGALODACTYLY *155540 : MELANOCORTIN 3 RECEPTOR; MC3R *155541 : MELANOCORTIN 4 RECEPTOR; MC4R *155550 : SILVER, MOUSE, HOMOLOG OF; SILV *155555 : MELANOCORTIN 1 RECEPTOR; MC1R *155600 : MELANOMA, CUTANEOUS MALIGNANT; CMM #155601 : MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2 155700 : MELANOMA, MALIGNANT INTRAOCULAR #155720 : MELANOMA, UVEAL *155730 : GRO1 ONCOGENE; GRO1 *155735 : MELANOMA ADHESION MOLECULE; MCAM *155740 : CD63 ANTIGEN; CD63 ^155741 : MOVED TO 600186 *155750 : MELANOMA-ASSOCIATED ANTIGEN p97; MFI2 #155755 : MELANOMA-ASTROCYTOMA SYNDROME *155760 : AGGRECAN 1; AGC1 155770 : MELANOMA TUMOR ANTIGEN GP90 *155800 : MELANOSIS, UNIVERSAL *155900 : MELKERSSON-ROSENTHAL SYNDROME 155950 : MELORHEOSTOSIS *155960 : MEMBRANE COMPONENT, CHROMOSOME 6, POLYPEPTIDE 2; M6P2 *155970 : MEMBRANE GLYCOPROTEIN MRC OX-2; MOX2 *155975 : MEMBRANE-BOUND IMMUNOGLOBULIN IgM-ALPHA; MB1 *155980 : MEMBRANOUS CRANIAL OSSIFICATION, DELAYED #156000 : MENIERE DISEASE *156100 : MENINGIOMA 1; MN1 156190 : MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA 156200 : MENTAL RETARDATION, DOMINANT 156220 : MERALGIA PARAESTHETICA, FAMILIAL *156225 : LAMININ, ALPHA-2; LAMA2 *156230 : MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE *156232 : MESOMELIC DYSPLASIA, KANTAPUTRA TYPE *156240 : MESOTHELIOMA, MALIGNANT 156250 : METACHONDROMATOSIS 156300 : METACHROMASIA OF FIBROBLASTS 156310 : METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A ^156340 : MOVED TO 156360 *156349 : METALLOTHIONEIN 1B; MT1B *156350 : METALLOTHIONEIN 1A; MT1A *156351 : METALLOTHIONEIN 1E; MT1E *156352 : METALLOTHIONEIN 1F; MT1F *156353 : METALLOTHIONEIN 1G; MT1G *156354 : METALLOTHIONEIN 1H; MT1H *156355 : METALLOTHIONEIN 1I; MT1I *156356 : METALLOTHIONEIN 1J; MT1J *156357 : METALLOTHIONEIN 1K; MT1K *156358 : METALLOTHIONEIN 1L; MT1L *156359 : METALLOTHIONEIN 1X; MT1X *156360 : METALLOTHIONEIN 2A; MT2A #156400 : METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE *156490 : NONMETASTATIC CELLS 1, PROTEIN EXPRESSED IN; NME1 *156491 : NONMETASTATIC CELLS 2, PROTEIN EXPRESSED IN; NME2 #156500 : METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS 156510 : METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY *156520 : METATARSUS VARUS, TYPE I 156530 : METATROPIC DYSPLASIA, NONLETHAL DOMINANT *156535 : METHYL-CpG-BINDING DOMAIN PROTEIN 1; MBD1 ^156536 : MOVED TO 600113 *156540 : METHYLTHIOADENOSINE PHOSPHORYLASE; MTAP #156550 : KNIEST DYSPLASIA *156560 : METHIONINE-tRNA SYNTHETASE; MARS *156565 : N-@METHYLPURINE DNA GLYCOSYLASE; MPG *156569 : METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT *156570 : 5-@METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR #156575 : MEVALONATE UPTAKE FACILITATOR; MEV *156580 : MICROCEPHALY, AUTOSOMAL DOMINANT 156590 : MICROCEPHALY WITH CHORIORETINOPATHY *156600 : MICROCORIA, CONGENITAL *156610 : MICHELIN TIRE BABY SYNDROME 156620 : MICROCEPHALY-DEAFNESS SYNDROME 156700 : MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES *156790 : MICROFIBRIL-ASSOCIATED PROTEIN 2; MFAP2 #156810 : MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD 156830 : MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL *156845 : MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF *156850 : MICROPHTHALMIA-CATARACT 156900 : MICROPHTHALMOS WITH MYOPIA AND CORECTOPIA 157100 : MICROPHTHALMOS, PIGMENTARY RETINOPATHY, AND GLAUCOMA *157129 : MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B *157130 : MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2 *157132 : MICROTUBULE-ASSOCIATED PROTEIN 4; MAP4 *157140 : MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT *157145 : MICROSEMINOPROTEIN, BETA; MSMB *157147 : MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN, 88-KD; MTP 157150 : MICROSPHEROPHAKIA WITH HERNIA 157151 : MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA 157160 : MICROTUBULE-ASSOCIATED PROTEIN TAU-LIKE; MAPTL #157170 : HOLOPROSENCEPHALY 2; HPE2 *157200 : MIDPHALANGEAL HAIR *157300 : MIGRAINE WITH AURA, SUSCEPTIBILITY TO; MGAU *157400 : MILIA, MULTIPLE ERUPTIVE ^157500 : MOVED TO 173310 157550 : MINICORE MYOPATHY, DOMINANT *157560 : MINISATELLITE 33.6 *157570 : MINISATELLITE 33.15 157600 : MIRROR MOVEMENTS, HEREDITARY #157640 : PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS; PEO 157650 : MITOCHONDRIAL MYOPATHY, LIPID TYPE *157655 : NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1; NDUFS1 *157660 : MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP *157670 : TRANSCRIPTION FACTOR 6-LIKE 1; TCF6L1 *157680 : CELL DIVISION CYCLE 25C; CDC25C *157700 : MITRAL VALVE PROLAPSE, FAMILIAL; MVP 157800 : MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES 157860 : MIXED LYMPHOCYTE CULTURE LOCUS II *157900 : MOEBIUS SYNDROME 1; MBS1 157910 : MOEBIUS SYNDROME WITH CLUBFOOT, ARTHROGRYPOSIS, AND DIGITAL ANOMALIES ^157920 : MOVED TO 309845 *157950 : MOLAR I REINCLUSION 157960 : MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2 *157970 : PROTEASOME 26S SUBUNIT, NON-ATPase, 7; PSMD7 ^157975 : MOVED TO 172411 157980 : MOMO SYNDROME #158000 : MONILETHRIX 158020 : ANTIGEN DEFINED BY MONOCLONAL ANTIBODY 4F2, LIGHT CHAIN *158030 : ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9; MSK1 *158040 : ANTIGEN DEFINED BY MONOCLONAL ANTIBODY T87; MSK2 *158050 : MONKEY RED BLOOD CELL RECEPTOR; MRBC *158070 : SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2; SLC3A2 158100 : MONOPHALANGY OF GREAT TOE *158105 : SMALL INDUCIBLE CYTOKINE A2; SCYA2 *158106 : SMALL INDUCIBLE CYTOKINE A7; SCYA7 *158120 : MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14 ^158130 : MOVED TO 158105 *158150 : MONOPHOSPHOGLYCERATE MUTASE #158170 : MONOSOMY 9p SYNDROME 158250 : MOSAICISM, CHROMOSOMAL *158270 : MOTILIN; MLN 158280 : MOTION SICKNESS *158300 : MOUTH, INABILITY TO OPEN COMPLETELY, AND SHORT FINGER-FLEXOR TENDONS *158310 : MUCOEPITHELIAL DYSPLASIA, HEREDITARY #158320 : MUIR-TORRE SYNDROME; MTS #158330 : MULLERIAN APLASIA *158340 : MUCIN 1, TRANSMEMBRANE; MUC1 *158343 : ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1 158345 : MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS #158350 : COWDEN DISEASE; CD *158370 : MUCIN 2, INTESTINAL; MUC2 *158371 : MUCIN 3A, INTESTINAL; MUC3A *158372 : MUCIN 4, TRACHEOBRONCHIAL; MUC4 *158373 : MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL; MUC5AC *158374 : MUCIN 6, GASTRIC; MUC6 *158375 : MUCIN 7, SALIVARY; MUC7 *158378 : SOLUTE CARRIER FAMILY 20, MEMBER 2; SLC20A2 *158380 : ECOTROPIC VIRAL INTEGRATION SITE 2A; EVI2A *158381 : ECOTROPIC VIRAL INTEGRATION SITE 2B; EVI2B *158400 : MUSCLE CRAMPS, FAMILIAL *158500 : MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS *158580 : MOTOR NEURONOPATHY, DISTAL HEREDITARY, WITH VOCAL CORD PARALYSIS *158590 : MUSCULAR ATROPHY, ADULT SPINAL *158600 : MUSCULAR ATROPHY, JUVENILE SPINAL 158650 : MUSCULAR ATROPHY, MALIGNANT NEUROGENIC #158700 : MUSCULAR ATROPHY, PROGRESSIVE, WITH AMYOTROPHIC LATERAL SCLEROSIS 158800 : MUSCULAR DYSTROPHY, BARNES TYPE #158810 : MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES *158900 : FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A *158901 : FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B; FSHMD1B #159000 : MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A #159001 : MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B *159050 : MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES 159100 : MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE 159300 : MUSICAL PERFECT PITCH *159350 : MUTATED IN COLORECTAL CANCERS; MCC 159400 : MYASTHENIA, FAMILIAL LIMB-GIRDLE *159405 : V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYBL1 159410 : MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS 159420 : MYDRIASIS, CONGENITAL *159430 : MYELIN BASIC PROTEIN; MBP *159440 : MYELIN PROTEIN ZERO; MPZ ^159455 : MOVED TO 170715 *159460 : MYELIN-ASSOCIATED GLYCOPROTEIN; MAG *159465 : MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MOG 159500 : MYELINATED OPTIC NERVE FIBERS *159530 : MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; MPL *159540 : LEUKEMIA-INHIBITORY FACTOR; LIF 159550 : MYELOCEREBELLAR DISORDER *159552 : MYELOID CELL LEUKEMIA 1; MCL1 *159553 : MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; MNDA *159555 : MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL *159556 : MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1 *159557 : MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 2; MLLT2 *159558 : MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 3; MLLT3 *159559 : MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 4; MLLT4 159580 : MYELOPATHY, HTLV-1-ASSOCIATED; HAM *159590 : CD33 ANTIGEN; CD33 *159595 : MYELOPROLIFERATIVE SYNDROME, TRANSIENT *159600 : MYOCLONIC EPILEPSY, HARTUNG TYPE 159700 : MYOCLONUS AND ATAXIA 159800 : MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS #159900 : MYOCLONIC DYSTONIA 159950 : MYOCLONUS, HEREDITARY, WITH PROGRESSIVE DISTAL MUSCULAR ATROPHY *159970 : MYOGENIC DIFFERENTIATION ANTIGEN 1; MYOD1 *159980 : MYOGENIC FACTOR 4; MYOG *159990 : MYOGENIC FACTOR 5; MYF5 *159991 : MYOGENIC FACTOR 6; MYF6 *160000 : MYOGLOBIN; MB *160010 : MYOGLOBINURIA, AUTOSOMAL DOMINANT *160100 : MYOKYMIA #160120 : EPISODIC ATAXIA, TYPE 1; EA1 #160150 : MYOPATHY, CENTRONUCLEAR 160200 : MYOPATHY, CONGENITAL, WITH CRYSTALLINE INTRANUCLEAR INCLUSIONS *160300 : MYOPATHY, DISTAL, WITH ONSET IN INFANCY *160500 : MYOPATHY, DISTAL 1; MPD1 160550 : MYOPATHY, MITOCHONDRIAL, WITH CATARACT *160565 : MYOPATHY, TUBULAR AGGREGATE 160570 : MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS *160700 : MYOPIA 2; MYP2 *160710 : MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6 *160720 : MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3 *160730 : MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1 *160740 : MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2 *160741 : MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8 *160742 : MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4 *160745 : MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE; MYH11 *160750 : MYOSITIS *160760 : MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7 *160770 : MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC; MYL4 *160775 : MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9 *160776 : MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10 *160777 : MYOSIN VA; MYO5A *160780 : MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST; MYL1 *160781 : MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2 *160782 : MYOSIN, LIGHT CHAIN 5, REGULATORY; MYL5 *160790 : MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3 *160793 : MYOSIN-BINDING PROTEIN C, FAST TYPE; MYBPC2 *160794 : MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1 *160795 : MYOSIN-BINDING PROTEIN H; MYBPH #160800 : MYOTONIA CONGENITA, AUTOSOMAL DOMINANT #160900 : DYSTROPHIA MYOTONICA 1 #160980 : CARNEY COMPLEX, TYPE 1; CNC1 160990 : MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS *160993 : N-MYRISTOYLTRANSFERASE 1; NMT1 *160994 : HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HNRPM *160995 : ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT1 *160998 : NAD(P)H:MENADIONE OXIDOREDUCTASE 1, DIOXIN-INDUCIBLE 2; NMOR2 *161000 : NAEGELI SYNDROME *161015 : NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1; NDUFV1 *161050 : NAIL DYSPLASIA 161070 : NAIL HIGH-SULFUR PROTEIN 161080 : NAIL LOW-SULFUR PROTEIN 161100 : NAILBEDS, PIGMENTATION OF #161200 : NAIL-PATELLA SYNDROME; NPS #161400 : NARCOLEPSY 161470 : NASAL ALAR COLLAPSE, BILATERAL 161480 : NASAL BONES, ABSENCE OF *161500 : NASAL GROOVE, FAMILIAL TRANSVERSE 161530 : NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE #161550 : NASOPHARYNGEAL CARCINOMA *161555 : KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1 *161560 : INTERLEUKIN 12A; IL12A *161561 : INTERLEUKIN 12B; IL12B *161565 : NATURAL KILLER TUMOR RECOGNITION SEQUENCE; NKTR 161600 : NAVICULAR BONE, ACCESSORY *161650 : NEBULIN; NEB 161700 : NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT #161800 : NEMALINE MYOPATHY 1, AUTOSOMAL DOMINANT; NEM1 *161900 : RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION *161950 : IgA NEPHROPATHY *162000 : NEPHROPATHY, FAMILIAL, WITH GOUT *162010 : NERVE GROWTH FACTOR RECEPTOR; NGFR 162020 : NERVE GROWTH FACTOR, ALPHA SUBUNIT; NGFA *162030 : NERVE GROWTH FACTOR, BETA SUBUNIT; NGFB *162040 : NERVE GROWTH FACTOR, GAMMA SUBUNIT; NGFG *162060 : GROWTH ASSOCIATED PROTEIN 43; GAP43 *162080 : NEURAL RETINA LEUCINE ZIPPER; NRL 162091 : SCHWANNOMATOSIS *162095 : PLEIOTROPHIN; PTN *162096 : NEURITE GROWTH-PROMOTING FACTOR 2; NEGF2 *162100 : NEURITIS WITH BRACHIAL PREDILECTION; NAPB *162150 : PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1; PCSK1 *162151 : PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2 *162200 : NEUROFIBROMATOSIS, TYPE I; NF1 #162210 : NEUROFIBROMATOSIS, FAMILIAL SPINAL 162220 : NEUROFIBROMATOSIS, FAMILIAL INTESTINAL; NF3B *162230 : NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE; NEFH 162240 : NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME *162250 : NEUROFILAMENT 3; NEF3 162260 : NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A 162270 : NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4 *162280 : NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL #162300 : MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B *162320 : TACHYKININ 1; TAC1 *162321 : TACHYKININ RECEPTOR 2; TACR2 *162323 : TACHYKININ RECEPTOR 1; TACR1 *162330 : TACHYKININ 3; TAC3 *162332 : TACHYKININ RECEPTOR 3; TACR3 *162340 : NEUROMEDIN B; NMB *162341 : NEUROMEDIN B RECEPTOR; NMBR *162350 : CEROID LIPOFUSCINOSIS, NEURONAL, DOMINANT OR PARRY TYPE *162360 : NESCIENT HELIX LOOP HELIX 1; NHLH1 *162361 : NESCIENT HELIX LOOP HELIX 2; NHLH2 *162370 : NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX *162375 : NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL DOMINANT 162380 : NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE #162400 : NEUROPATHY, HEREDITARY SENSORY, TYPE I; HSN1 #162500 : NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP 162600 : NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE *162640 : NEUROPEPTIDE Y; NPY *162641 : NEUROPEPTIDE Y RECEPTOR Y1; NPY1R *162642 : NEUROPEPTIDE Y RECEPTOR Y2; NPY2R *162643 : CHEMOKINE (C-X-C) RECEPTOR 4; CXCR4 *162650 : NEUROTENSIN; NTS *162651 : NEUROTENSIN RECEPTOR 1; NTSR1 *162660 : NEUROTROPHIN 3; NTF3 ^162661 : MOVED TO 162662 *162662 : NEUROTROPHIN 5; NTF5 *162700 : NEUTROPENIA, CHRONIC FAMILIAL #162800 : CYCLIC HEMATOPOIESIS *162815 : NEUTROPHIL AZUROCIDIN; NAZC *162820 : NEUTROPHIL CHEMOTACTIC RESPONSE; NCR 162830 : NEUTROPHILIA, HEREDITARY *162860 : NEUTROPHIL-SPECIFIC ANTIGEN: NB ^162870 : MOVED TO 146740 *162880 : NEUTROPHIL-SPECIFIC ANTIGEN: ND1 *162890 : NEUTROPHIL-SPECIFIC ANTIGEN: NE1 *162900 : NEVI *163000 : NEVI FLAMMEI, FAMILIAL MULTIPLE 163050 : NEVUS ANEMICUS *163100 : NEVUS FLAMMEUS OF NAPE OF NECK 163200 : NEVUS SEBACEUS OF JADASSOHN *163260 : NUCLEAR FACTOR ERYTHROID 2-LIKE 1; NFE2L1 *163400 : NIEVERGELT SYNDROME #163500 : NIGHT BLINDNESS, CONGENITAL STATIONARY; CSNB3 163600 : NIPPLES INVERTED *163700 : NIPPLES, SUPERNUMERARY *163728 : NITRIC OXIDE SYNTHASE, CHONDROCYTE *163729 : NITRIC OXIDE SYNTHASE 3; NOS3 *163730 : NITRIC OXIDE SYNTHASE 2A; NOS2A *163731 : NITRIC OXIDE SYNTHASE 1; NOS1 *163800 :